1194
|
Partially hydrolyzed eggshell membrane powder derived from chicken eggs
|
|
Pending
|
|
|
1193
|
D-psicose
|
|
Pending
|
|
|
1192
|
Tannase enzyme preparation produced by Aspergillus oryzae
|
|
Pending
|
|
|
1191
|
Ergothioneine produced by Escherichia coli BL-21 (DE3) expressing ergothioneine synthases from Schizosaccharomyces pombe
|
|
Pending
|
|
|
1190
|
Saccharomyces cerevisiae strain OYR-481 expressing a gene encoding acetolactate decarboxylase from Brevibacillus brevis
|
|
Pending
|
|
|
1189
|
Dry whole goat milk
|
|
Pending
|
|
|
1188
|
D-psicose
|
|
Pending
|
|
|
1187
|
Polygalacturonase enzyme preparation produced by Trichoderma reesei expressing a gene encoding polygalacturonase from Aspergillus luchuensis mut kawachii
|
|
Pending
|
|
|
1186
|
Fungal oil (≥38% arachidonic acid (ARA)) from Mortierella alpina FJRK-MA01
|
|
Pending
|
|
|
1185
|
Algal oil (≥35% docosahexaenoic acid) from Schizochytrium sp. FJRK-SCH3
|
|
Pending
|
|
|
1184
|
Rebaudioside M from a modified strain of Escherichia coli BL21(DE3)
|
|
Pending
|
|
|
1183
|
Monellin preparation produced by Komagataella phaffii P-MON-040 expressing a gene encoding for a modified monellin
|
|
Pending
|
|
|
1182
|
Hydroxytyrosol
|
|
Pending
|
|
|
1181
|
Weizmannia coagulans LMG S-31876 spore preparation
|
|
Pending
|
|
|
1180
|
Cellobiose
|
|
Pending
|
|
|
1179
|
Liquid whole cow milk
|
|
Pending
|
|
|
1178
|
Rebaudioside I obtained by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside I)
|
|
Pending
|
|
|
1177
|
Bacillus coagulans “Unique IS-2” spore preparation
|
|
Pending
|
|
|
1176
|
Lacto-N-tetraose
|
|
Pending
|
|
|
1175
|
Lactiplantibacillus plantarum DSM 23881
|
|
Pending
|
|
|
1174
|
Dry whole goat milk
|
|
Pending
|
|
|
1173
|
Invertase enzyme preparation produced by Trichoderma reesei expressing a gene for invertase from Aspergillus niger
|
|
Pending
|
|
|
1172
|
Liquid milk, either whole or nonfat, combined with lactose and water
|
|
Pending
|
|
|
1171
|
Non-animal type 21 collagen polypeptide
|
|
Pending
|
|
|
1170
|
Resistant dextrin from tapioca in powder or syrup form
|
|
Pending
|
|
|
1169
|
6′-sialyllactose sodium salt
|
|
Pending
|
|
|
1168
|
Tigernuts flour
|
|
Pending
|
|
|
1167
|
Brazzein produced by Komagataella phaffii expressing a gene encoding for brazzein from Pentadiplandra brazzeana
|
|
Pending
|
|
|
1166
|
Fava bean (Vicia faba L.) protein hydrolysate
|
|
Pending
|
|
|
1165
|
(R)-1,3-butanediol
|
|
Pending
|
|
|
1164
|
A chemically synthesized analog of pediocin PA-1 specific to Listeria monocytogenes
|
|
Pending
|
|
|
1163
|
A preparation containing two bacteriophages (phage) specific to Salmonella enterica
|
|
Pending
|
|
|
1162
|
Fungal oil (≥38% arachidonic acid (ARA)) from Mortierella alpina FJRK-MA01
|
Feb 8, 2024
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (236 kB)
|
|
|
1161
|
Triacylglycerol lipase enzyme preparation produced by Candida cylindracea
|
|
Pending
|
|
|
1160
|
Lemna leaf protein
|
|
Pending
|
|
|
1159
|
Bacillus coagulans strain BCP92 spore preparation
|
|
Pending
|
|
|
1158
|
Lactiplantibacillus plantarum DSM 34613
|
|
Pending
|
|
|
1157
|
2'-fucosyllactose
|
|
Pending
|
|
|
1156
|
Algal oil (≥35% docosahexaenoic acid) from Schizochytrium sp. FJRK-SCH3
|
Feb 8, 2024
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (204 kB)
|
|
|
1155
|
1-methylcyclopropene complex
|
Apr 23, 2024
|
FDA has no questions (in PDF) (208 kB)
|
|
|
1154
|
Triacylglycerol lipase enzyme preparation produced by Komagataella phaffii expressing the gene encoding lipase from Fusarium oxysporum
|
|
Pending
|
|
|
1153
|
Pongamia bean oil
|
|
Pending
|
|
|
1152
|
Phoenix oyster mushroom (Pleurotus pulmonarius) mycelia biomass
|
|
Pending
|
|
|
1151
|
Fava bean protein
|
|
Pending
|
|
|
1150
|
Triacylglycerol lipase enzyme preparation produced by Trichoderma reesei expressing a gene for triacylglycerol lipase from Thermomyces lanuginosis
|
|
Pending
|
|
|
1149
|
High-selenium Saccharomyces cerevisiae yeast
|
Dec 12, 2023
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (98 kB)
|
|
|
1148
|
D-psicose
|
|
Pending
|
|
|
1147
|
Copper(II) ion
|
|
Pending
|
|
|
1146
|
Nuclease enzyme preparation produced by Bacillus amyloliquefaciens expressing the gene encoding a nuclease from Serratia marcescens
|
Jun 12, 2024
|
FDA has no questions (in PDF) (181 kB)
|
|
|
1145
|
β-lactoglobulin produced by Aspergillus oryzae strain Ao_st0002
|
|
Pending
|
|
|
1144
|
Miracle fruit (Synsepalum dulcificum) powder
|
|
Pending
|
|
|
1143
|
Bacillus subtilis NRRL 68053
|
Jan 19, 2024
|
FDA has no questions (in PDF) (222 kB)
|
|
|
1142
|
Brazzein produced by Komagataella phaffii expressing a gene encoding for brazzein from Pentadiplandra brazzeana
|
Mar 11, 2024
|
FDA has no questions (in PDF) (257 kB)
|
|
|
1141
|
L-α-glycerophosphorylcholine
|
|
Pending
|
|
|
1140
|
Enzyme-modified steviol glycosides
|
Oct 17, 2023
|
FDA has no questions (in PDF) (251 kB)
|
|
|
1139
|
Transglutaminase enzyme preparation produced by Bacillus licheniformis carrying a gene encoding transglutaminase from Streptomyces mobaraensis
|
|
Pending
|
|
|
1138
|
Hydroxytyrosol
|
Sep 28, 2023
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (173 kB)
|
|
|
1137
|
Protein-sucrose
|
Jan 19, 2024
|
FDA has no questions (in PDF) (188 kB)
|
|
|
1136
|
Dry whole goat milk
|
Oct 31, 2023
|
FDA has no questions (in PDF) (267 kB)
|
|
|
1135
|
Galacto-oligosaccharides
|
Nov 3, 2023
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (133 kB)
|
|
|
1134
|
Bacteriophage preparation specific to Salmonella Enteritidis
|
Feb 8, 2024
|
FDA has no questions (in PDF) (180 kB)
|
|
|
1133
|
Resistant dextrin from corn
|
|
Pending
|
|
|
1132
|
Hydrolyzed poultry protein
|
Jan 29, 2024
|
FDA has no questions (in PDF) (224 kB)
|
|
|
1131
|
Bacillus subtilis ATCC BS50 PTA-127287
|
Oct 20, 2023
|
FDA has no questions (in PDF) (267 kB)
|
|
|
1130
|
Lactobacillus rhamnosus CGMCC21225
|
Sep 28, 2023
|
FDA has no questions (in PDF) (248 kB)
|
|
|
1129
|
Heat-killed Clostridium tyrobutyricum strain ASM#19
|
|
Pending
|
|
|
1128
|
Algal oil (≥35% docosahexaenoic acid) from Schizochytrium sp.
|
|
Pending
|
|
|
1127
|
Lactiplantibacillus plantarum ATCC-202195
|
Feb 1, 2024
|
FDA has no questions (in PDF) (235 kB)
|
|
|
1126
|
Calcium acetate
|
|
Pending
|
|
|
1125
|
Pea protein fermented by shiitake mycelia
|
Mar 27, 2024
|
FDA has no questions (in PDF) (462 kB)
|
|
|
1124
|
β-glucans from Hericium erinaceus strain BCRC 35669
|
Sep 28, 2023
|
At the notifier's request, FDA Ceased to evaluate this notice (in PDF) (209 kB)
|
|
|
1123
|
Sucrose fatty acid esters
|
Nov 3, 2023
|
FDA has no questions (in PDF) (214 kB)
|
|
|
1122
|
Canola concentrate
|
|
Pending
|
|
|
1121
|
Fructanase enzyme preparation produced by Trichoderma reesei expressing the gene encoding fructanase from Lactobacillus sp.
|
Feb 15, 2024
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (109 kB)
|
|
|
1120
|
α-galactosidase enzyme preparation produced by Aspergillus niger
|
|
Pending
|
|
|
1119
|
Olea europaea L. leaf extract
|
|
Pending
|
|
|
1118
|
Pyrroloquinoline quinone disodium salt
|
Jul 31, 2023
|
FDA has no questions (in PDF) (353 kB)
|
|
|
1117
|
Mycelial biomass from Neurospora crassa
|
|
Pending
|
|
|
1116
|
Shea stearin
|
|
Pending
|
|
|
1115
|
Fungal oil (≥40% arachidonic acid (ARA)) from Mortierella alpina strain AF
|
Sep 18, 2023
|
FDA has no questions (in PDF) (256 kB)
|
|
|
1114
|
Bifidobacterium breve DSM 33444
|
Jul 10, 2023
|
FDA has no questions (in PDF) (141 kB)
|
|
|
1113
|
Lactobacillus plantarum NCIMB 30562
|
Jul 20, 2023
|
FDA has no questions (in PDF) (419 kB)
|
|
|
1112
|
Limosilactobacillus reuteri strain ATCC PTA-126787 and L. reuteri strain ATCC PTA-126788, in combination, on a 1:1 ratio of colony forming unit (CFU) basis
|
|
Pending
|
|
|
1111
|
Endo-1,4-β-xylanase enzyme preparation produced by Bacillus subtilis expressing the gene encoding xylanase from B. subtilis
|
Feb 15, 2024
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (136 kB)
|
|
|
1110
|
Polygalacturonase enzyme preparation produced by Trichoderma reesei expressing a gene encoding a polygalacturonase from Aspergillus kawachii
|
Feb 14, 2024
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (185 kB)
|
|
|
1109
|
β-agarase enzyme preparation produced by Streptomyces coelicolor
|
|
Pending
|
|
|
1108
|
Lactiplantibacillus plantarum strain MCC 0537
|
Aug 16, 2023
|
FDA has no questions (In PDF) (290 kB)
|
|
|
1107
|
Bifidobacterium longum subsp. infantis strain LMG 11588
|
Nov 15, 2023
|
FDA has no questions (in PDF) (241 kB)
|
|
|
1106
|
Rebaudioside I obtained by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside I)
|
Jun 16, 2023
|
FDA has no questions (in PDF) (277 kB)
|
|
|
1105
|
Polyglycerol polyricinoleic acid
|
Jun 14, 2023
|
FDA has no questions (in PDF) (225 kB)
|
|
|
1104
|
Egg-white protein produced by Komagataella phaffii ATCC GSD-1235
|
Oct 17, 2023
|
FDA has no questions (in PDF) (264 kB)
|
|
|
1103
|
Canola protein isolate
|
|
Pending
|
|
|
1102
|
Invertase enzyme preparation produced by Trichoderma reesei expressing a gene for invertase from Aspergillus niger
|
Feb 15, 2024
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (132 kB)
|
|
|
1101
|
Dried biomass of Chlamydomonas reinhardtii strain TAI114
|
Sep 1, 2023
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (161 kB)
|
|
|
1100
|
Fractionated whey protein concentrate containing 41% alpha-lactalbumin
|
Oct 27, 2023
|
FDA has no questions (259 kB)
|
|
|
1099
|
3-fucosyllactose
|
Aug 29, 2023
|
FDA has no questions (in PDF) (292 kB)
|
|
|
1098
|
Chickpea protein concentrate
|
|
Pending
|
|
|
1097
|
Maltogenic alpha-amylase enzyme preparation produced by Escherichia coli expressing a gene encoding a maltogenic alpha-amylase from Geobacillus stearothermophilus
|
Dec 7, 2023
|
FDA has no questions (in PDF) (247 kB)
|
|
|
1096
|
Saccharomyces cerevisiae strain OYR-243
|
Jul 5, 2023
|
FDA has no questions (in PDF) (212 kB)
|
|
|
1095
|
Bacillus subtilis strain ATCC AAN000002 spore preparation
|
Sep 11, 2023
|
FDA has no questions (in PDF) (286 kB)
|
|
|
1094
|
Saccharomyces cerevisiae strain BY-989 expressing a gene encoding a carbon-sulfur lyase from Citrobacter freundii
|
|
Pending
|
|
|
1093
|
Lacticaseibacillus rhamnosus IDCC 3201
|
Jun 9, 2023
|
FDA has no Questions (265 kB)
|
|
|
1092
|
Bifidobacterium animalis subsp. lactis IDCC 4301
|
Jun 23, 2023
|
FDA has no Questions (271 kB)
|
|
|
1091
|
2'-fucosyllactose
|
Dec 1, 2023
|
FDA has no questions (in PDF) (272 kB)
|
|
|
1090
|
Bifidobacterium bifidum strain NITE BP-31
|
Apr 5, 2023
|
FDA has no questions (in PDF) (209 kB)
|
|
|
1089
|
Lactobacillus gasseri strain NCIMB 30370
|
Jun 20, 2023
|
FDA has no questions (in PDF) (244 kB)
|
|
|
1088
|
Lactococcus lactis strain KCTC 11865BP
|
|
Pending
|
|
|
1087
|
Streptococcus thermophilus strain KCTC 11870BP
|
|
Pending
|
|
|
1086
|
Lactobacillus plantarum KCTC 10782BP
|
Oct 27, 2023
|
FDA has no questions (in PDF) (291 kB)
|
|
|
1085
|
Lactobacillus casei strain KCTC 12398BP
|
Oct 27, 2023
|
FDA has no questions (in PDF) (313 kB)
|
|
|
1084
|
Lactobacillus rhamnosus KCTC 12202BP
|
Oct 31, 2023
|
FDA has no questions (in PDF) (247 kB)
|
|
|
1083
|
Lactobacillus acidophilus KCTC 11906BP
|
Oct 31, 2023
|
FDA has no questions (in PDF) (218 kB)
|
|
|
1082
|
Bifidobacterium lactis strain KCTC 11904BP
|
Oct 31, 2023
|
FDA has no questions (267 kB)
|
|
|
1081
|
Bifidobacterium infantis strain KCTC 11859BP
|
|
Pending
|
|
|
1080
|
Bifidobacterium breve strain KCTC 12201BP
|
|
Pending
|
|
|
1079
|
Bifidobacterium longum strain KCTC 12200BP
|
Oct 31, 2023
|
FDA has no questions (in PDF) (240 kB)
|
|
|
1078
|
Bifidobacterium bifidum strain KCTC 12199BP
|
Oct 31, 2023
|
FDA has no questions (in PDF) (239 kB)
|
|
|
1077
|
Oat polar lipid extract
|
|
Pending
|
|
|
1076
|
Galacto-oligosaccharides
|
Mar 2, 2023
|
FDA has no questions (in PDF) (245 kB)
|
|
|
1075
|
6'-sialyllactose sodium salt
|
Mar 22, 2023
|
FDA has no questions (in PDF) (286 kB)
|
|
|
1074
|
3'-sialyllactose sodium salt
|
Apr 5, 2023
|
FDA has no Questions (in PDF) (383 kB)
|
|
|
1073
|
Corn bran arabinoxylan
|
Mar 21, 2023
|
FDA has no questions (in PDF) (247 kB)
|
|
|
1072
|
Lemnaceae fiber
|
Jan 30, 2023
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (229 kB)
|
|
|
1071
|
Glucose oxidase enzyme preparation produced by Saccharomyces cerevisiae expressing a gene encoding a glucose oxidase from Aspergillus niger
|
|
Pending
|
|
|
1070
|
Preparations containing six bacteriophages (phage) specific to Salmonella enterica
|
Mar 10, 2023
|
FDA has no Questions (in PDF) (279 kB)
|
|
|
1069
|
Corn protein
|
|
Pending
|
|
|
1068
|
Lacto-N-tetraose
|
Jun 5, 2023
|
FDA has no questions (in PDF) (302 kB)
|
|
|
1067
|
Lacto-N-neotetraose
|
Apr 4, 2023
|
FDA has no questions (in PDF) (306 kB)
|
|
|
1066
|
Carnobacterium divergens strain M35
|
|
Pending
|
|
|
1065
|
Anaerobutyricum soehngenii CH106
|
Apr 14, 2023
|
FDA has no questions (in PDF) (222 kB)
|
|
|
1064
|
Pomegranate extract
|
|
Pending
|
|
|
1063
|
Weissella cibaria CMU
|
Apr 14, 2023
|
FDA has no questions (in PDF) (254 kB)
|
|
|
1062
|
Saccharomyces cerevisiae strain OYR-185
|
Apr 5, 2023
|
FDA has no questions (in PDF) (214 kB)
|
|
|
1061
|
Deactivated alkaline serine protease produced by Bacillus licheniformis strain CICC 10266
|
|
Pending
|
|
|
1060
|
2'-fucosyllactose
|
Apr 4, 2023
|
FDA has no questions (in PDF) (333 kB)
|
|
|
1059
|
Lacto-N-neotetraose
|
Dec 2, 2022
|
FDA has no questions (in PDF) (288 kB)
|
|
|
1058
|
Polyvinyl alcohol
|
Jun 9, 2023
|
FDA has no questions (in PDF) (283 kB)
|
|
|
1057
|
D-psicose
|
Jan 25, 2024
|
FDA has no questions (in PDF) (298 kB)
|
|
|
1056
|
β-lactoglobulin produced by Komagataella phaffii strain yRMK-66
|
Feb 15, 2023
|
FDA Has No Questions (in PDF) (291 kB)
|
|
|
1055
|
Xylanase enzyme preparation produced by Bacillus licheniformis strain expressing the xylanase gene from Chryseobacterium
|
Apr 4, 2023
|
FDA Has No Questions (in PDF) (265 kB)
|
|
|
1054
|
Glucose oxidase enzyme preparation produced by Aspergillus niger expressing the gene encoding glucose oxidase from A. niger
|
Jul 14, 2023
|
FDA has no questions (in PDF) (270 kB)
|
|
|
1053
|
6'-sialyllactose sodium salt
|
May 12, 2023
|
FDA Has No Questions (in PDF) (266 kB)
|
|
|
1052
|
3'-sialyllactose sodium salt
|
Apr 18, 2023
|
FDA has no questions (in PDF) (292 kB)
|
|
|
1051
|
2'-fucosyllactose
|
Nov 21, 2023
|
FDA has no questions (in PDF) (298 kB)
|
|
|
1050
|
High 2-palmitic acid vegetable oil
|
Jul 18, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (175 kB)
|
|
|
1049
|
Medium-chain triacylglycerols
|
Sep 21, 2022
|
FDA has no questions (in PDF) (249 kB)
|
|
|
1048
|
Aminopeptidase enzyme preparation produced by Trichoderma reesei expressing a gene encoding an aminopeptidase from Aspergillus clavatus
|
|
Pending
|
|
|
1047
|
Lipase enzyme preparation produced by Saccharomyces cerevisiae expressing a gene encoding a lipase from Fusarium oxysporum
|
|
Pending
|
|
|
1046
|
Collagenase enzyme preparation from genetically modified Streptomyces violaceoruber expressing a collagenase gene
|
Jun 22, 2023
|
FDA has no questions (in PDF) (219 kB)
|
|
|
1045
|
Resistant dextrin from tapioca
|
Aug 26, 2022
|
FDA has no Questions (in PDF) (250 kB)
|
|
|
1044
|
Calcium disodium ethylenediaminetetraacetic acid
|
May 25, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (118 kB)
|
|
|
1043
|
Cetylated fatty acids
|
Oct 26, 2022
|
FDA has no Questions (in PDF) (187 kB)
|
|
|
1042
|
Menaquinone-7 derived from a specific strain of Bacillus subtilis natto
|
Apr 3, 2023
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (188 kB)
|
|
|
1041
|
Dry whole milk
|
May 10, 2022
|
FDA has no questions (in PDF) (2.0 MB)
|
|
|
1040
|
2'-fucosyllactose
|
Sep 22, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (116 kB)
|
|
|
1039
|
Lactase enzyme preparation produced by Aspergillus oryzae
|
Apr 6, 2023
|
FDA has no questions (195 kB)
|
|
|
1038
|
Preparation containing six bacteriophages (phage) specific to Salmonella enterica spp. serovars
|
May 11, 2023
|
FDA has no questions (in PDF) (333 kB)
|
|
|
1037
|
3-fucosyllactose
|
Nov 7, 2022
|
FDA has no questions (in PDF) (287 kB)
|
|
|
1036
|
Complexation products of iron with sodium citrate
|
Oct 6, 2022
|
FDA Has No Questions (in PDF) (285 kB)
|
|
|
1035
|
Lacto-N-fucopentaose I with 2'-fucosyllactose
|
Jan 19, 2023
|
FDA has no questions (in PDF) (288 kB)
|
Mar 1, 2023
|
|
1034
|
2'-fucosyllactose
|
Oct 21, 2022
|
FDA has no questions (in PDF) (258 kB)
|
|
|
1033
|
Hydrolyzed Saccharomyces cerevisiae
|
|
Pending
|
|
|
1032
|
D-β-hydroxybutyrate
|
Jun 2, 2022
|
FDA has no questions (in PDF) (214 kB)
|
|
|
1031
|
Barley and rice protein hydrolysate
|
Oct 20, 2022
|
FDA has no questions (in PDF) (219 kB)
|
|
|
1030
|
Cellulase enzyme preparation produced by Aspergillus niger genetically engineered to express a cellulase gene from Trichoderma reesei
|
Feb 15, 2023
|
FDA has no questions (in PDF) (286 kB)
|
|
|
1029
|
D-psicose
|
Aug 4, 2023
|
FDA has no questions (in PDF) (255 kB)
|
|
|
1028
|
Metschnikowia pulcherrima DANMET-A and M. fructicola DANMET-B
|
Nov 21, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (306 kB)
|
|
|
1027
|
Miracle fruit (Synsepalum dulcificum) powder
|
Dec 22, 2021
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (137 kB)
|
|
|
1026
|
Silk fibroin derived from Bombyx mori cocoons
|
Aug 11, 2022
|
FDA has no questions (in PDF) (185 kB)
|
|
|
1025
|
Pepsin A enzyme preparation produced by Pichia pastoris to overexpress the gene encoding pepsin A
|
Jan 6, 2023
|
FDA Has No Questions (in PDF) (318 kB)
|
|
|
1024
|
D-psicose
|
Mar 2, 2023
|
FDA Has no Questions (in PDF) (253 kB)
|
|
|
1023
|
Monosodium L-5-methyltetrahydrofolate
|
Jan 25, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (85 kB)
|
|
|
1022
|
Streptococcus salivarius DB-B5
|
Aug 22, 2022
|
FDA has no questions (in PDF) (177 kB)
|
|
|
1021
|
Transglutaminase enzyme preparation produced by Streptomyces mobaraensis strain M2020197
|
Nov 3, 2022
|
FDA has no questions (in PDF) (395 kB)
|
|
|
1020
|
Protein from Helianthus annuus (sunflower protein)
|
Jun 14, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (101 kB)
|
|
|
1019
|
Agave mixed fructans from Agave tequilana Weber var. azul
|
Feb 27, 2023
|
FDA has no questions (in PDF) (271 kB)
|
|
|
1018
|
Carbon monoxide
|
Aug 11, 2022
|
FDA has no questions (in PDF) (254 kB)
|
|
|
1017
|
Lacto-N-tetraose
|
Aug 23, 2022
|
FDA has no questions (in PDF) (245 kB)
|
|
|
1016
|
6'-sialyllactose sodium salt
|
Jul 15, 2022
|
FDA has no questions (in PDF) (237 kB)
|
|
|
1015
|
3'-sialyllactose sodium salt
|
Jul 15, 2022
|
FDA has no questions (in PDF) (234 kB)
|
|
|
1014
|
2-fucosyllactose
|
Jul 15, 2022
|
FDA has no questions (in PDF) (295 kB)
|
|
|
1013
|
Lactobacillus rhamnosus DSM 33156
|
Dec 15, 2021
|
FDA has no questions (in PDF) (310 kB)
|
|
|
1012
|
Powdered sap from Angelica keiskei (ashitaba) containing 8% chalcones (ashitaba sap)
|
Apr 7, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (108 kB)
|
|
|
1011
|
Alpha-amylase enzyme preparation produced by Bacillus subtilis strain AR-651 expressing the gene encoding alpha-amylase from Thermoactinomyces vulgaris
|
Jul 18, 2022
|
FDA has no questions (in PDF) (294 kB)
|
|
|
1010
|
Rebaudioside M obtained by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni)
|
Jan 26, 2022
|
FDA has no questions (in PDF) (412 kB)
|
|
|
1009
|
Water-soluble palm fruit extract
|
Jun 24, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (129 kB)
|
|
|
1008
|
Algal oil (≥45% docosahexaenoic acid) from Aurantiochytrium limacinum TKD-1
|
Feb 25, 2022
|
FDA has no questions (in PDF) (166 kB)
|
|
|
1007
|
Bacillus subtilis strain R0179
|
Dec 16, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (184 kB)
|
|
|
1006
|
Short-chain fructooligosaccharides
|
Jan 19, 2022
|
FDA has no questions (in PDF) (177 kB)
|
|
|
1005
|
β-Lactoglobulin from cow milk
|
Mar 3, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF)
|
|
|
1004
|
Maltosyltrehalose syrup
|
Jan 20, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (84 kB)
|
|
|
1003
|
Bifidobacterium longum subsp. infantis M-63
|
Apr 26, 2022
|
FDA has no questions (in PDF) (75 kB)
|
|
|
1002
|
Bifidobacterium breve strain MCC1274
|
Jul 22, 2022
|
FDA has no questions (in PDF) (221 kB)
|
|
|
1001
|
Myoglobin preparation from a strain of Pichia pastoris expressing the myoglobin gene from Bos taurus
|
Dec 3, 2021
|
FDA has no questions (in PDF) (375 kB)
|
|
|
1000
|
Phycocyanin-rich extract of Galdieria sulphuraria (G. sulphuraria strain FCC3424)
|
Mar 8, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (160 kB)
|
|
|
999
|
Enzyme-modified steviol glycosides
|
Dec 3, 2021
|
FDA has no questions (in PDF) (172 kB)
|
|
|
998
|
Corn bran arabinoxylan
|
Oct 25, 2021
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (101 kB)
|
|
|
997
|
Chitosan and beta-1,3-glucans from white button mushrooms (Agaricus bisporus)
|
Feb 28, 2022
|
FDA has no questions (in PDF) (140 kB)
|
Dec 18, 2023
|
|
996
|
Synthetic amorphous silica
|
Feb 4, 2022
|
FDA has no questions (in PDF) (137 kB)
|
|
|
995
|
β-glucans from Antrodia cinnamomea strain ATCC 200183
|
Jun 14, 2022
|
FDA has no questions (in PDF) (162 kB)
|
|
|
994
|
Miracle fruit (Synsepalum dulcificum), in pulp, powder, or protein forms
|
Oct 26, 2021
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (140 kB)
|
|
|
993
|
L-carnitine-L-tartrate
|
Oct 18, 2021
|
FDA has no questions (in PDF) (149 kB)
|
|
|
992
|
White mulberry (Morus alba Linn) leaf extract
|
May 6, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (97 kB)
|
|
|
991
|
Chitosanase enzyme preparation produced by Bacillus subtilis
|
Aug 31, 2022
|
FDA has no questions (in PDF) (225 kB)
|
|
|
990
|
Short-chain fructooligosaccharides
|
Oct 8, 2021
|
FDA has no questions (in PDF) (109 kB)
|
|
|
989
|
Bacillus subtilis expressing a modified gene encoding a variant of the wild-type subtilisin from B. clausii
|
Jun 30, 2022
|
FDA has no questions (in PDF) (144 kB)
|
|
|
988
|
Lactobacillus fermentum LfQi6
|
Mar 28, 2022
|
FDA has no questions (in PDF) (138 kB)
|
|
|
987
|
2'-fucosyllactose
|
Feb 2, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (236 kB)
|
|
|
986
|
Chlorella sorokiniana powder and C. sorokiniana micro powder
|
Dec 21, 2021
|
FDA has no questions (in PDF) (148 kB)
|
|
|
985
|
Bifidobacterium longum subsp. infantis strain ATCC SD 6720
|
Dec 21, 2021
|
FDA has no questions (in PDF) (339 kB)
|
|
|
984
|
Wolffia globosa
|
Oct 8, 2021
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (429 kB)
|
|
|
983
|
Purified steviol glycosides from the leaves of Stevia rebaudiana (Bertoni)
|
Jun 28, 2021
|
FDA has no questions (in PDF) (202 kB)
|
|
|
982
|
Polygalacturonase enzyme preparation produced by Aspergillus oryzae expressing a polygalacturonase gene from A. tubingensis Mosseray
|
Feb 2, 2022
|
FDA has no questions (in PDF) (154 kB)
|
|
|
981
|
Sterol esterase enzyme preparation produced by Trichoderma reesei expressing a gene encoding sterol esterase from Melanocarpus albomyces
|
May 10, 2022
|
FDA has no questions (in PDF) (255 kB)
|
|
|
980
|
Dry whole milk
|
Jul 13, 2021
|
FDA has no questions (in PDF) (124 kB)
|
|
|
979
|
Pectin esterase enzyme preparation produced by Aspergillus oryzae expressing a pectin esterase gene from A. tubingensis
|
Oct 18, 2021
|
FDA has no questions (in PDF) (140 kB)
|
|
|
978
|
Hydrolyzed aqueous olive pulp extract
|
Dec 10, 2021
|
FDA has no questions (in PDF) (256 kB)
|
|
|
977
|
D-tagatose produced via novel enzymatic cascade
|
Oct 21, 2021
|
FDA has no questions (in PDF) (153 kB)
|
|
|
976
|
Sodium hyaluronate
|
May 24, 2021
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (185 kB)
|
|
|
975
|
Maltogenic alpha-amylase enzyme preparation produced by Bacillus licheniformis carrying the gene coding for maltogenic alpha-amylase from Geobacillus stearothermophilus
|
Jul 8, 2021
|
FDA has no questions (in PDF) (313 kB)
|
|
|
974
|
Maltogenic alpha-amylase enzyme preparation produced by Bacillus subtilis
|
Feb 2, 2022
|
FDA has no questions (in PDF) (310 kB)
|
|
|
973
|
Maple wood fiber
|
May 13, 2021
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (169 kB)
|
|
|
972
|
Pectin hydrolysate from carrot pomace
|
Mar 25, 2022
|
FDA has no questions (124 kB)
|
|
|
971
|
Bacillus clausii strain 088AE spore preparation
|
Mar 3, 2022
|
FDA has no questions (in PDF) (150 kB)
|
|
|
970
|
Enzyme-modified steviol glycosides
|
Apr 9, 2021
|
FDA has no questions (in PDF) (225 kB)
|
|
|
969
|
Bacillus subtilis Bss-19 spore preparation
|
Oct 6, 2021
|
FDA has no questions (in PDF)
|
|
|
968
|
Rebaudioside B
|
Mar 10, 2022
|
FDA has no questions (in PDF) (227 kB)
|
|
|
967
|
Soluble egg-white protein produced by Komagataella phaffii strain GSD-1209
|
Sep 9, 2021
|
FDA has no questions (in PDF) (305 kB)
|
|
|
966
|
Preparations containing three to eight bacteriophages specific to Campylobacter jejuni
|
Oct 6, 2021
|
FDA has no questions (in PDF) (312 kB)
|
|
|
965
|
Arabinase enzyme preparation produced by Aspergillus tubingensis
|
Jul 20, 2021
|
FDA has no questions (in PDF) (500 kB)
|
|
|
964
|
Lysophospholipase enzyme preparation from Aspergillus niger produced by Trichoderma reesei
|
Sep 9, 2021
|
FDA has no questions (in PDF) (158 kB)
|
|
|
963
|
Fungal oil (≥40% arachidonic acid) from Mortierella alpina
|
Oct 19, 2021
|
FDA has no questions (in PDF) (429 kB)
|
|
|
962
|
Rice bran wax
|
Mar 17, 2022
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (138 kB)
|
|
|
961
|
β-glucan derived from Agrobacterium sp. CCTCC No. M2010020
|
May 19, 2021
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (229 kB)
|
|
|
960
|
Hypromellose acetate succinate
|
Dec 21, 2021
|
FDA has no questions (126 kB)
|
|
|
959
|
Iron milk proteinate
|
Mar 17, 2021
|
FDA has no questions (in PDF) (208 kB)
|
|
|
958
|
Fungal oil (≥40% arachidonic acid) from Mortierella alpina strain AF
|
Mar 26, 2021
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (94 kB)
|
|
|
957
|
Lactobacillus johnsonii strain ATCC PTA-124205
|
Oct 26, 2021
|
FDA has no questions (in PDF) (172 kB)
|
|
|
956
|
Bacillus subtilis ATCC SD-7280
|
Aug 18, 2021
|
FDA has no questions (in PDF) (131 kB)
|
|
|
955
|
Bacillus subtilis strain BS-MB40 PTA-122264 spore preparation
|
Mar 26, 2021
|
FDA has no questions (in PDF) (243 kB)
|
Sep 11, 2023
|
|
954
|
Fibrillated cellulose
|
Jun 10, 2021
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (111 kB)
|
|
|
953
|
Lactobacillus plantarum strain CECT 7527, CECT 7528, and CECT 7529
|
Feb 5, 2021
|
FDA has no questions (in PDF)
|
|
|
952
|
Bifidobacterium animalis subsp. lactis strain AD011 (Resubmission of GRN 875)
|
Mar 17, 2021
|
FDA has no questions (in PDF) (160 kB)
|
|
|
951
|
3-fucosyllactose
|
Aug 12, 2021
|
FDA has no questions (in PDF) (272 kB)
|
|
|
950
|
Bifidobacterium longum subsp. infantis DSM 33361
|
Mar 1, 2021
|
FDA has no questions (in PDF) (281 kB)
|
|
|
949
|
Bacillus coagulans strain DSM 17654 spore preparation
|
Jan 7, 2021
|
FDA has no questions (in PDF)
|
|
|
948
|
Enzyme-treated pea protein
|
Sep 9, 2021
|
FDA has no questions (in PDF) (151 kB)
|
|
|
947
|
Cacao pulp and cacao fruit juice concentrate
|
Dec 21, 2021
|
FDA has no questions (in PDF) (145 kB)
|
|
|
946
|
Lactobacillus plantarum strain DSM 33452
|
Feb 5, 2021
|
FDA has no questions (in PDF) (91 kB)
|
|
|
945
|
Fungal protein from Fusarium sp. mycelia
|
Apr 22, 2022
|
FDA has no questions (in PDF) (142 kB)
|
|
|
944
|
Rice protein hydrolysate
|
Oct 8, 2021
|
FDA has no questions (in PDF) (280 kB)
|
|
|
943
|
Citrus fiber from the peels of oranges, lemons, or limes
|
Apr 9, 2021
|
FDA has no questions (in PDF) (181 kB)
|
|
|
942
|
Whey permeate
|
Dec 21, 2020
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (189 kB)
|
|
|
941
|
Oat polar lipid extract
|
Jun 11, 2021
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (124 kB)
|
|
|
940
|
Phospholipase A2 enzyme from Sus scrofa (wild pig) produced by Yarrowia lipolytica
|
May 12, 2021
|
FDA has no questions (in PDF) (540 kB)
|
|
|
939
|
Sunflower lecithin
|
Mar 3, 2021
|
FDA has no questions (in PDF) (109 kB)
|
|
|
938
|
Pichia kluyveri DSM 33235
|
Apr 14, 2021
|
FDA has no questions (in PDF) (147 kB)
|
|
|
937
|
Staphylococcus carnosus DSM 25010
|
Apr 21, 2021
|
FDA has no questions (in PDF) (195 kB)
|
|
|
936
|
Leuconostoc carnosum DSM 32756
|
Apr 19, 2021
|
FDA has no questions (in PDF) (212 kB)
|
|
|
935
|
L-carnitine-L-tartrate
|
Nov 30, 2020
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (242 kB)
|
|
|
934
|
Algal oil (≥35% docosahexanoic acid (DHA)) derived from Schizochytrium sp. strain CABIO-A-2
|
Jul 20, 2021
|
FDA has no questions (in PDF) (214 kB)
|
|
|
933
|
Algal oil (≥36% docosahexaenoic acid) from Schizochytrium sp. strain DHF
|
Nov 13, 2020
|
FDA has no questions (in PDF) (757 kB)
|
|
|
932
|
2'-fucosyllactose
|
Feb 18, 2021
|
FDA has no questions (in PDF) (223 kB)
|
|
|
931
|
Creatine monohydrate
|
Nov 12, 2020
|
FDA has no questions (in PDF) (437 kB)
|
|
|
930
|
Silk fibroin derived from Bombyx mori cocoons
|
May 25, 2021
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (128 kB)
|
|
|
929
|
2'-fucosyllactose
|
Feb 26, 2021
|
FDA has no questions (267 kB)
|
|
|
928
|
Dried Saccharomyces cerevisiae yeast fermentate
|
May 14, 2021
|
FDA has no questions (in PDF) (248 kB)
|
|
|
927
|
Polyvinyl alcohol
|
Feb 26, 2021
|
FDA has no questions (in PDF) (206 kB)
|
|
|
926
|
Soluble rice flour
|
Jan 5, 2021
|
FDA has no questions (in PDF) (434 kB)
|
|
|
925
|
3-fucosyllactose
|
Feb 8, 2021
|
FDA has no questions (in PDF) (190 kB)
|
|
|
924
|
2'-fucosyllactose
|
Nov 23, 2020
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF)
|
|
|
923
|
Lacto-N-tetraose
|
Feb 2, 2021
|
FDA has no questions (in PDF) (187 kB)
|
|
|
922
|
6'-sialyllactose sodium salt
|
Apr 23, 2021
|
FDA has no questions (in PDF) (224 kB)
|
|
|
921
|
3'-sialyllactose sodium salt
|
Oct 30, 2020
|
FDA has no questions (in PDF) (771 kB)
|
|
|
920
|
Thaumatin II
|
Nov 24, 2020
|
FDA has no questions (in PDF) (170 kB)
|
|
|
919
|
Lacto-N-neotetraose
|
Oct 30, 2020
|
FDA has no questions (in PDF) (353 kB)
|
|
|
918
|
Partially defatted almond protein flour
|
Jul 7, 2021
|
FDA has no questions (206 kB)
|
|
|
917
|
Preparation containing three bacterial phages specific to Salmonella
|
Sep 10, 2020
|
FDA has no questions (in PDF) (540 kB)
|
|
|
916
|
Dihydroquercetin
|
May 19, 2021
|
FDA has no questions (in PDF) (245 kB)
|
|
|
915
|
Calcium L-methylfolate
|
Feb 23, 2021
|
FDA has no questions (in PDF) (217 kB)
|
|
|
914
|
Alpha-linolenic acid diacylglycerol
|
Mar 15, 2021
|
FDA has no questions (in PDF) (175 kB)
|
|
|
913
|
Algal oil (minimum 35% DHA)
|
Nov 10, 2020
|
FDA has no questions (in PDF) (906 kB)
|
|
|
912
|
Trehalose
|
Oct 1, 2021
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (141 kB)
|
|
|
911
|
Rebaudioside I
|
Jun 8, 2021
|
FDA has no questions (in PDF) (208 kB)
|
|
|
910
|
Thaumatin II
|
Sep 9, 2020
|
FDA has no questions (in PDF) (541 kB)
|
|
|
909
|
Whey protein containing 41% alpha-lactalbumin
|
Sep 8, 2021
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (127 kB)
|
|
|
908
|
Lipase from Penicillium camemberti
|
Feb 5, 2021
|
FDA has no questions (in PDF) (184 kB)
|
|
|
907
|
Wheat seed oil
|
Aug 21, 2020
|
FDA has no questions (in PDF) (593 kB)
|
|
|
906
|
Wheat seed polar lipids
|
Aug 24, 2020
|
FDA has no questions (in PDF) (573 kB)
|
|
|
905
|
Bacillus subtilis SG188
|
Jun 8, 2020
|
FDA has no questions (in PDF) (659 kB)
|
|
|
904
|
Fungal protein from fermented Fusarium sp. mycelia
|
Mar 26, 2021
|
FDA has no questions (in PDF) (956 kB)
|
|
|
903
|
Quillaia extract type 2
|
Apr 21, 2021
|
FDA has no questions (in PDF) (195 kB)
|
|
|
902
|
Neohesperidin dihydrochalcone
|
Nov 23, 2020
|
FDA has no questions (in PDF) (409 kB)
|
|
|
901
|
Glucosyl hesperidin
|
Nov 9, 2020
|
FDA has no questions (in PDF) (670 kB)
|
|
|
900
|
Corn oil
|
Oct 30, 2020
|
FDA has no questions (in PDF) (540 kB)
|
|
|
899
|
Citric acid esters of mono- and diglycerides
|
Oct 30, 2020
|
FDA has no questions (in PDF) (624 kB)
|
|
|
898
|
Anhydrous milk fat
|
Oct 28, 2020
|
FDA has no questions (in PDF) (650 kB)
|
|
|
897
|
2'-O-fucosyllactose
|
Jun 12, 2020
|
FDA has no questions (in PDF) (715 kB)
|
|
|
896
|
Alpha-galacto-oligosaccharides
|
Sep 18, 2020
|
FDA has no questions (in PDF) (202 kB)
|
|
|
895
|
Lacto-N-neotetraose
|
Dec 3, 2020
|
FDA has no questions (in PDF) (858 kB)
|
|
|
894
|
White mulberry leaf extract
|
Nov 19, 2020
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (201 kB)
|
|
|
893
|
D-psicose
|
Jun 5, 2020
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (58 kB)
|
|
|
892
|
Refined shea butter
|
Jul 7, 2020
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (162 kB)
|
|
|
891
|
Cellulase produced by Trichoderma reesei
|
Oct 20, 2020
|
FDA has no questions (in PDF)
|
|
|
890
|
Corn oil derived from distillers grains
|
Dec 23, 2020
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (189 kB)
|
|
|
889
|
Spermidine rich wheat germ extract
|
Mar 20, 2020
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (236 kB)
|
|
|
888
|
Preparation containing three bacterial phages specific to Salmonella
|
Feb 28, 2020
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (36 kB)
|
|
|
887
|
Menaquinone-7
|
Jun 12, 2020
|
FDA has no questions (in PDF) (472 kB)
|
|
|
886
|
Monoacylglycerides from grape seed
|
Jul 13, 2020
|
FDA has no questions (508 kB)
|
May 24, 2024
|
|
885
|
Vinyl acetate-vinyl laurate copolymer
|
Apr 22, 2020
|
FDA has no questions (in PDF) (451 kB)
|
|
|
884
|
Rice bran extract
|
Aug 19, 2020
|
FDA has no questions (in PDF) (518 kB)
|
|
|
883
|
Ilex guayusa leaf aqueous extract
|
Apr 28, 2020
|
FDA has no questions (in PDF) (46 kB)
|
|
|
882
|
Rebaudioside M
|
Feb 2, 2020
|
FDA has no questions (in PDF) (479 kB)
|
|
|
881
|
6'-sialyllactose sodium salt
|
Feb 24, 2020
|
FDA has no questions (in PDF) (562 kB)
|
|
|
880
|
3'-sialyllactose sodium salt
|
Feb 21, 2020
|
FDA has no questions (in PDF) (557 kB)
|
|
|
879
|
Fava bean protein isolate
|
Mar 23, 2020
|
FDA has no questions (in PDF) (502 kB)
|
|
|
878
|
Glucosylated steviol glycosides
|
Dec 19, 2019
|
FDA has no questions (in PDF) (453 kB)
|
May 11, 2020
|
|
877
|
Bifidobacterium longum BB536
|
Dec 26, 2019
|
FDA has no questions (in PDF) (75 kB)
|
|
|
876
|
Hydroxytyrosol
|
Jan 21, 2020
|
FDA has no questions (in PDF) (88 kB)
|
|
|
875
|
Bifidobacterium animalis subsp. lactis AD011
|
Oct 30, 2019
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (258 kB)
|
|
|
874
|
Corn protein
|
Apr 29, 2020
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (44 kB)
|
|
|
873
|
Cranberry extract
|
May 6, 2020
|
FDA has no questions (in PDF) (567 kB)
|
|
|
872
|
Bifidobacterium animalis subsp. lactis UABla-12
|
Dec 9, 2019
|
FDA has no questions (in PDF) (62 kB)
|
|
|
871
|
Lactobacillus acidophilus DDS-1
|
Oct 23, 2019
|
FDA has no questions (in PDF) (49 kB)
|
|
|
870
|
Ilex guayusa leaf hydroethanolic extract
|
Mar 20, 2020
|
FDA has no questions (in PDF) (550 MB)
|
|
|
869
|
Ilex guayusa leaf aqueous extract
|
Mar 20, 2020
|
FDA has no questions (in PDF) (550 kB)
|
|
|
868
|
Coffee fruit extract
|
Mar 24, 2020
|
FDA has no questions (in PDF) (556 kB)
|
|
|
867
|
Rebaudioside M
|
Sep 3, 2019
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (36 kB)
|
|
|
866
|
Lipase from Penicillium camemberti
|
Feb 5, 2020
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (257 kB)
|
|
|
865
|
Lactobacillus acidophilus NCFM
|
Mar 10, 2020
|
FDA has no questions (in PDF) (761 kB)
|
|
|
864
|
Bacillus coagulans SNZ 1969 spore preparation
|
Feb 6, 2020
|
FDA has no questions (in PDF) (560 kB)
|
|
|
863
|
β-lactoglobulin produced by Trichoderma reesei
|
Mar 25, 2020
|
FDA has no questions (in PDF) (637 kB)
|
|
|
862
|
Algal oil (40% docosahexaenoic acid) from Schizochytrium sp. strain ONC-T18
|
Jun 15, 2020
|
FDA has no questions (in PDF) (748 kB)
|
|
|
861
|
Pullulanase from Bacillus deramificans produced in Bacillus subtilis
|
Jul 21, 2020
|
FDA has no questions (in PDF) (605 kB)
|
|
|
860
|
Algal oil (36% docosahexaenoic acid) from Schizochytrium sp. strain DHF
|
Sep 3, 2019
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (59 kB)
|
|
|
859
|
2'-fucosyllactose
|
Sep 6, 2019
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (106 kB)
|
|
|
858
|
Glucosylated steviol glycosides
|
Oct 4, 2019
|
FDA has no questions (in PDF) (86 kB)
|
|
|
857
|
Phospholipase A1 produced by Aspergillus niger
|
Dec 20, 2019
|
FDA has no questions (in PDF) (465 kB)
|
|
|
856
|
Bifidobacterium animalis subsp. lactis strain BB-12
|
Dec 9, 2019
|
FDA has no questions (in PDF) (63 kB)
|
|
|
855
|
Bifidobacterium animalis subsp. lactis strain R0421
|
Feb 5, 2020
|
FDA has no questions (in PDF) (634 kB)
|
|
|
854
|
Agave mixed fructans from Agave tequilana
|
Jan 21, 2020
|
FDA has no questions (in PDF) (2.0 MB)
|
|
|
853
|
Lysozyme produced by Trichoderma reesei
|
May 27, 2020
|
FDA has no questions (in PDF) (552 kB)
|
|
|
852
|
2'-fucosyllactose
|
Nov 15, 2019
|
FDA has no questions (in PDF) (108 kB)
|
|
|
851
|
Pea protein
|
Apr 15, 2020
|
FDA has no questions (in PDF) (601 kB)
|
|
|
850
|
Olein from shea tree nut extract
|
Mar 20, 2020
|
FDA has no questions (in PDF) (610 kB)
|
|
|
849
|
Inulin from artichoke
|
Oct 30, 2019
|
FDA has no questions (in PDF) (129 kB)
|
|
|
848
|
Pea and rice protein fermented by shiitake mycelia
|
Jan 9, 2020
|
FDA has no questions (in PDF) (479 kB)
|
|
|
847
|
Lactobacillus plantarum ECGC 13110402
|
Sep 30, 2019
|
FDA has no questions (in PDF) (86 kB)
|
|
|
846
|
Rebaudioside M
|
Aug 23, 2019
|
FDA has no questions (in PDF) (102 kB)
|
|
|
845
|
Lactobacillus rhamnosus LGG
|
Oct 30, 2019
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (121 kB)
|
|
|
844
|
Algal oil (55% docosahexaenoic acid) from Schizochytrium sp. strain FCC-3204
|
Oct 18, 2019
|
FDA has no questions (in PDF) (105 kB)
|
|
|
843
|
Algal oil (35% docosahexaenoic acid) from Schizochytrium sp. strain FCC-1324
|
Oct 18, 2019
|
FDA has no questions (in PDF) (85 kB)
|
|
|
842
|
Maltogenic alpha-amylase
|
Jan 21, 2020
|
FDA has no questions (in PDF)
|
|
|
841
|
Saccharomyces cerevisiae expressing L-lactate dehydrogenase from Rhizopus oryzae
|
Mar 10, 2020
|
FDA has no questions (in PDF) (604 kB)
|
|
|
840
|
Lactobacillus paracasei strain F19
|
Aug 27, 2019
|
FDA has no questions (in PDF) (76 kB)
|
|
|
839
|
Purified steviol glycosides
|
Jul 8, 2019
|
FDA has no questions (in PDF) (77 kB)
|
|
|
838
|
Purified steviol glycosides
|
Jul 12, 2019
|
FDA has no questions (in PDF) (83 kB)
|
|
|
837
|
Hydroxytyrosol
|
Jun 5, 2019
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (54 kB)
|
|
|
836
|
Algal oil (50-60% docosahexaenoic acid) from Schizochytrium sp. HS01
|
Sep 3, 2019
|
FDA has no questions (in PDF) (74 kB)
|
|
|
835
|
Ilex guayusa leaf extract
|
May 22, 2019
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (35 kB)
|
|
|
834
|
Preparation containing bacterial phages specific to shiga-toxin producing Escherichia coli
|
Nov 8, 2019
|
FDA has no questions (in PDF) (91 kB)
|
Jan 12, 2024
|
|
833
|
Lacto-N-tetraose
|
Oct 7, 2019
|
FDA has no questions (in PDF) (702 kB)
|
|
|
832
|
Acid prolyl endopeptidase produced by Aspergillus niger
|
Dec 9, 2019
|
FDA has no questions (in PDF) (285 kB)
|
|
|
831
|
Bacillus subtilis DE111
|
Aug 13, 2019
|
FDA has no questions (in PDF) (73 kB)
|
|
|
830
|
Chicory flour
|
May 22, 2019
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (54 kB)
|
|
|
829
|
Powdered Aspergillus oryzae grown with one or more added minerals
|
Dec 9, 2019
|
FDA has no questions (in PDF) (110 kB)
|
May 18, 2020
|
|
828
|
D-psicose
|
Mar 2, 2020
|
FDA has no questions (in PDF) (550 kB)
|
|
|
827
|
Preparation containing three bacterial phages specific to several Escherichia coli serotypes
|
Aug 12, 2019
|
FDA has no questions (in PDF) (76 kB)
|
Oct 9, 2019
|
|
826
|
Dihydroquercetin
|
Sep 25, 2019
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (35 kB)
|
|
|
825
|
Beta-galactosidase from Kluyveromyces lactis
|
Nov 7, 2019
|
FDA has no questions (in PDF) (64 kB)
|
|
|
824
|
Bacteriocin preparations specific to Salmonella
|
Oct 21, 2019
|
FDA has no questions (in PDF) (71 kB)
|
|
|
823
|
Rebaudioside E
|
Jun 21, 2019
|
FDA has no questions (in PDF) (757 kB)
|
|
|
822
|
Curcumin
|
Jun 4, 2019
|
FDA has no questions (in PDF) (861 kB)
|
|
|
821
|
Glucosylated steviol glycosides
|
May 7, 2019
|
FDA has no questions (in PDF) (743 kB)
|
|
|
820
|
Lactobacillus fermentum CECT5716
|
Apr 3, 2019
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (35 kB)
|
|
|
819
|
Fatty acid ethyl esters from Alaskan Pollock
|
Sep 3, 2019
|
FDA has no questions (in PDF) (63 kB)
|
|
|
818
|
Isomalto-oligosaccharides
|
Dec 18, 2019
|
FDA has no questions (in PDF) (126 kB)
|
|
|
817
|
Serine endopeptidase from Malbranchea cinnamomea produced in Trichoderma reesei
|
Aug 26, 2019
|
FDA has no questions (in PDF) (68 kB)
|
|
|
816
|
Xylooligosaccharides from sugarcane
|
Apr 29, 2019
|
FDA has no questions (in PDF) (160 kB)
|
|
|
815
|
2'-fucosyllactose and difucosyllactose
|
Aug 20, 2019
|
FDA has no questions (in PDF) (250 kB)
|
Sep 11, 2020 May 7, 2020
|
|
814
|
Bifidobacterium bifidum BGN4
|
Jun 25, 2019
|
FDA has no questions (in PDF) (78 kB)
|
|
|
813
|
Bifidobacterium longum BORI
|
Jun 21, 2019
|
FDA has no questions (in PDF) (82 kB)
|
|
|
812
|
Rebaudioside M
|
Dec 8, 2018
|
FDA has no questions (in PDF) (659 kB)
|
|
|
811
|
Phospholipase A1 produced by Aspergillus oryzae
|
Jul 19, 2019
|
FDA has no questions (in PDF) (64 kB)
|
|
|
810
|
Lactobacillus paracasei subsp. paracasei strain F-19e
|
Apr 5, 2019
|
FDA has no questions (in PDF) (178 kB)
|
|
|
809
|
Fractionated whey protein concentrate containing 41% alpha-lactalbumin
|
May 6, 2019
|
FDA has no questions (in PDF) (315 kB)
|
|
|
808
|
Lipase from Aspergillus tubingensis produced in Trichoderma reesei
|
May 28, 2019
|
FDA has no questions (in PDF) (79 kB)
|
|
|
807
|
Streptococcus salivarius M18
|
Apr 18, 2019
|
FDA has no questions (in PDF) (62 kB)
|
|
|
806
|
Dolomite
|
May 17, 2019
|
FDA has no questions (in PDF) (276 kB)
|
|
|
805
|
Apple peel powder
|
Mar 8, 2019
|
FDA has no questions (in PDF) (522 kB)
|
|
|
804
|
Pea protein
|
Nov 8, 2019
|
FDA has no questions (in PDF) (94 kB)
|
|
|
803
|
Pea protein
|
Nov 8, 2019
|
FDA has no questions (in PDF) (91 kB)
|
|
|
802
|
Endolysin
|
May 10, 2019
|
FDA has no questions (in PDF) (290 kB)
|
|
|
801
|
Chymosin enzyme from Camelus dromedarius produced in Aspergillus niger
|
Jun 6, 2019
|
FDA has no questions (in PDF) (71 kB)
|
|
|
800
|
gamma-oryzanol
|
Mar 8, 2019
|
FDA has no questions (in PDF) (628 kB)
|
|
|
799
|
Rebaudioside M
|
Sep 25, 2018
|
FDA has no questions (in PDF) (112 kB)
|
|
|
798
|
Saccharomyces cerevisiae strain yBBS002
|
Aug 13, 2019
|
FDA has no questions (in PDF) (74 kB)
|
|
|
797
|
Fructooligosaccharides
|
Nov 15, 2018
|
FDA has no questions (in PDF) (454 kB)
|
|
|
796
|
Orange extract (85% hesperidin)
|
Feb 20, 2019
|
FDA has no questions (in PDF) (458 kB)
|
|
|
795
|
Purified steviol glycosides
|
Sep 25, 2018
|
FDA has no questions (in PDF) (105 kB)
|
|
|
794
|
Shiitake, pea, and rice protein fermented with Lentinula edodes
|
Nov 9, 2018
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (53 kB)
|
|
|
793
|
Cultured corn starch fermented by Corynebacterium stationis
|
Apr 26, 2019
|
FDA has no questions (in PDF) (171 kB)
|
|
|
792
|
Cultured corn starch fermented by Corynebacterium glutamicum
|
Apr 26, 2019
|
FDA has no questions (in PDF) (160 kB)
|
|
|
791
|
Urolithin A
|
Dec 20, 2018
|
FDA has no questions (in PDF) (145 kB)
|
|
|
790
|
Steviol glycosides (minimum purity 95%)
|
Feb 26, 2019
|
FDA has no questions (in PDF) (448 kB)
|
|
|
789
|
Erythritol
|
Feb 20, 2019
|
FDA has no questions (in PDF) (79 kB)
|
|
|
788
|
Pea protein concentrate
|
Oct 12, 2018
|
FDA has no questions (in PDF) (249 kB)
|
|
|
787
|
Quinoa sprout powder
|
Sep 9, 2018
|
FDA has no questions (in PDF) (94 kB)
|
|
|
786
|
Calcium propionate
|
Nov 20, 2018
|
FDA has no questions (in PDF) (74 kB)
|
|
|
785
|
Calcium chloride
|
Nov 20, 2018
|
FDA has no questions (in PDF) (74 kB)
|
|
|
784
|
Siraitia grosvenorii Swingle (Luo Han Guo) fruit juice concentrate
|
Nov 20, 2018
|
FDA has no questions (in PDF) (664 kB)
|
|
|
783
|
Triacylglycerol lipase from Rhizopus oryzae produced in Aspergillus niger
|
Dec 20, 2018
|
FDA has no questions (in PDF) (75 kB)
|
|
|
782
|
L-arabinose
|
Aug 29, 2018
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (47 kB)
|
|
|
781
|
Alpha-tocopherol (fruit and vegetable derived)
|
Nov 5, 2018
|
FDA has no questions (in PDF) (1 MB)
|
|
|
780
|
Rebaudioside M
|
Jul 31, 2018
|
FDA has no questions (in PDF) (115 kB)
|
|
|
779
|
Isomalto-oligosaccharide mixture
|
Oct 19, 2018
|
FDA has no questions (in PDF) (92 kB)
|
|
|
778
|
Hemp seed oil
|
Dec 20, 2018
|
FDA has no questions (in PDF) (434 kB)
|
Feb 10, 2020
|
|
777
|
Algal oil (55% docosahexaenoic acid) from Schizochytrium sp. strain FCC-3204
|
Oct 26, 2018
|
FDA has no questions (in PDF) (233 kB)
|
|
|
776
|
Algal oil (35% docosahexaenoic acid) from Schizochytrium sp. strain FCC-1324
|
Oct 26, 2018
|
FDA has no questions (in PDF) (573 kB)
|
|
|
775
|
Colicin preparations
|
Oct 26, 2018
|
FDA has no questions (in PDF) (80 kB)
|
|
|
774
|
Glutaminase from Bacillus licheniformis produced in Bacillus licheniformis
|
Nov 26, 2018
|
FDA has no questions (in PDF) (73 kB)
|
|
|
773
|
Dried biomass of Chlamydomonas reinhardtii
|
Feb 22, 2019
|
FDA has no questions (in PDF) (148 kB)
|
|
|
772
|
Palmitoylated green tea catechins
|
Dec 13, 2018
|
FDA has no questions (in PDF) (63 kB)
|
|
|
771
|
Hemp seed protein
|
Dec 20, 2018
|
FDA has no questions (in PDF) (484 kB)
|
Feb 10, 2020
|
|
770
|
Potassium polyaspartate
|
Sep 11, 2018
|
FDA has no questions (in PDF) (789 kB)
|
|
|
769
|
Vitamin C (fruit and vegetable derived)
|
Oct 23, 2018
|
FDA has no questions (in PDF) (72 kB)
|
|
|
768
|
Stevia leaf extract
|
Aug 13, 2018
|
FDA has no questions (in PDF) (100 kB)
|
|
|
767
|
Polyvinyl alcohol
|
Sep 7, 2018
|
FDA has no questions (in PDF) (57 kB)
|
|
|
766
|
3'-sialyllactose sodium salt
|
Sep 26, 2018
|
FDA has no questions (in PDF) (920 kB)
|
|
|
765
|
Dehulled hemp seed
|
Dec 20, 2018
|
FDA has no questions (in PDF) (278 kB)
|
Feb 10, 2020
|
|
764
|
Rebaudioside D
|
Jul 10, 2018
|
FDA has no questions (in PDF) (111 kB)
|
|
|
763
|
Alpha-lactalbumin
|
Dec 10, 2018
|
FDA has no questions (in PDF) (106 kB)
|
|
|
762
|
Carnobacterium divergens M35 preparation
|
Aug 14, 2018
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (31 kB)
|
|
|
761
|
Esterified propoxylated glycerol
|
May 25, 2018
|
FDA has no questions (in PDF) (105 kB)
|
|
|
760
|
Lactobacillus curvatus DSM 18775
|
Jan 29, 2019
|
FDA has no questions (in PDF) (77 kB)
|
|
|
759
|
Steviol glycosides consisting primarily of rebaudioside M produced in Yarrowia lipolytica
|
May 25, 2018
|
FDA has no questions (in PDF) (106 kB)
|
|
|
758
|
Lactobacillus helveticus R0052, Bifidobacterium longum subsp. infantis R0033, and Bifidobacterium bifidum R0071
|
Aug 20, 2018
|
FDA has no questions (in PDF) (103 kB)
|
|
|
757
|
Preparation containing two bacterial phages specific to Escherichia coli O157
|
Aug 3, 2018
|
FDA has no questions (in PDF) (67 kB)
|
Oct 25, 2019
|
|
756
|
Endo-1,4-beta-glucanase from Trichoderma reesei
|
Sep 12, 2018
|
FDA has no questions (in PDF) (93 kB)
|
|
|
755
|
D-psicose
|
May 10, 2018
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (56 kB)
|
|
|
754
|
Algal oil (87% oleic acid) derived from Prototheca moriformis strain S6697
|
Jul 23, 2018
|
FDA has no questions (in PDF) (111 kB)
|
|
|
753
|
Sodium thiocyanate
|
Jul 31, 2018
|
FDA has no questions (in PDF) (56 kB)
|
|
|
752
|
Preparation containing the bacterial monophages, BP-63 and LVR16-A, specific to Salmonella
|
Jul 13, 2018
|
FDA has no questions (in PDF) (57 kB)
|
Jan 7, 2022
|
|
751
|
Maltogenic alpha-amylase from Bacillus stearothermophilus produced in Bacillus subtilis
|
Jul 31, 2018
|
FDA has no questions (in PDF) (228 kB)
|
|
|
750
|
Beta-glucosidase from Aspergillus niger
|
Oct 2, 2018
|
FDA has no questions (in PDF) (767 kB)
|
|
|
749
|
2'-O-fucosyllactose
|
Apr 23, 2018
|
FDA has no questions (in PDF) (95 kB)
|
|
|
748
|
Tomato powder
|
Apr 19, 2018
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (44 kB)
|
|
|
747
|
Calcium lactate
|
Jun 1, 2018
|
FDA has no questions (in PDF) (76 kB)
|
|
|
746
|
Maltogenic amylase from Geobacillus stearothermophilus produced in Bacillus subtilis
|
Jun 13, 2018
|
FDA has no questions (in PDF) (104 kB)
|
|
|
745
|
Steviol glycosides consisting primarily of rebaudioside M
|
Apr 20, 2018
|
FDA has no questions (in PDF) (103 kB)
|
|
|
744
|
Steviol glycosides consisting primarily of rebaudioside M
|
Mar 23, 2018
|
FDA has no questions (in PDF) (131 kB)
|
|
|
743
|
β-galactosidase from Papiliotrema terrestris
|
Jun 1, 2018
|
FDA has no questions (in PDF) (68 kB)
|
|
|
742
|
Duckweed (subfamily Lemnoideae) powder
|
Aug 22, 2018
|
FDA has no questions (in PDF) (64 kB)
|
|
|
741
|
Dimethyl ether
|
May 18, 2018
|
FDA has no questions (in PDF) (72 kB)
|
|
|
740
|
Glycolipids from Dacryopinax spathularia
|
May 17, 2018
|
FDA has no questions (in PDF) (93 kB)
|
Aug 25, 2023
|
|
739
|
Mannanase enzyme from Talaromyces leycettanus produced in Aspergillus niger
|
Apr 25, 2018
|
FDA has no questions (in PDF) (113 kB)
|
|
|
738
|
Thaumatin
|
Apr 18, 2018
|
FDA has no questions (in PDF) (77 kB)
|
|
|
737
|
Soy leghemoglobin preparation from a strain of Pichia pastoris (Resubmission of GRN 540)
|
Jul 23, 2018
|
FDA has no questions (in PDF) (80 kB)
|
|
|
736
|
Lactobacillus casei subsp. paracasei Lpc-37
|
Apr 11, 2018
|
FDA has no questions (in PDF) (73 kB)
|
|
|
735
|
2'-Fucosyllactose
|
Apr 6, 2018
|
FDA has no questions (in PDF) (103 kB)
|
Apr 30, 2020
|
|
734
|
Ergothioneine
|
May 7, 2018
|
FDA has no questions (in PDF) (70 kB)
|
|
|
733
|
Purified steviol glycosides
|
Jan 9, 2018
|
FDA has no questions (in PDF) (69 kB)
|
|
|
732
|
Docosahexaenoic acid oil produced in Schizochytrium sp.
|
Apr 6, 2018
|
FDA has no questions (in PDF) (68 kB)
|
|
|
731
|
Docosahexaenoic acid oil produced in Schizochytrium sp.
|
Apr 6, 2018
|
FDA has no questions (in PDF) (72 kB)
|
|
|
730
|
Arachidonic-acid rich oil from Mortierella alpina strain LU 166
|
Mar 30, 2018
|
FDA has no questions (in PDF) (77 kB)
|
|
|
729
|
Galacto-oligosaccharides
|
Mar 27, 2018
|
FDA has no questions (in PDF) (112 kB)
|
|
|
728
|
Phospholipase C from Pseudomonas sp. 62186 produced in Bacillus licheniformis
|
Nov 13, 2017
|
FDA has no questions (in PDF) (47 kB)
|
|
|
727
|
Trehalase from Trichoderma reesei produced in Trichoderma reesei
|
Mar 5, 2018
|
FDA has no questions (in PDF) (61 kB)
|
|
|
726
|
Phenolic preparation from olive fruit
|
Feb 28, 2018
|
FDA has no questions (in PDF) (66 kB)
|
|
|
725
|
Inactivated Bacillus coagulans GBI-30, 6086
|
Feb 12, 2018
|
FDA has no questions (in PDF) (52 kB)
|
|
|
724
|
Preparation containing six bacterial phages specific to shiga-toxin producing Escherichia coli
|
Apr 10, 2018
|
FDA has no questions (in PDF) (75 kB)
|
|
|
723
|
Benzalkonium chloride
|
Dec 18, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (41 kB)
|
|
|
722
|
Lactobacillus plantarum Lp-115
|
Feb 16, 2018
|
FDA has no questions (in PDF) (67 kB)
|
|
|
721
|
Galacto-oligosaccharides
|
Dec 19, 2017
|
FDA has no questions (in PDF) (69 kB)
|
|
|
720
|
Rice bran wax
|
Jan 16, 2018
|
FDA has no questions (in PDF) (73 kB)
|
|
|
719
|
Orange pomace and enzyme-treated orange pomace
|
Dec 26, 2017
|
FDA has no questions (in PDF) (66 kB)
|
|
|
718
|
Calcium acid pyrophosphate
|
Oct 17, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (32 kB)
|
|
|
717
|
Short-chain fructo-oligosaccharides
|
Feb 13, 2018
|
FDA has no questions (in PDF) (82 kB)
|
Apr 21, 2023
|
|
716
|
Bovine milk osteopontin
|
Feb 1, 2018
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (32 kB)
|
|
|
715
|
Rebaudioside D
|
Oct 24, 2017
|
FDA has no questions (in PDF) (69 kB)
|
|
|
714
|
Subtilisin from Bacillus amyloliquefaciens produced in Bacillus subtilis
|
Feb 6, 2018
|
FDA has no questions (in PDF) (53 kB)
|
|
|
713
|
Hydrolyzed pork cartilage
|
Apr 5, 2018
|
FDA has no questions (in PDF) (65 kB)
|
|
|
712
|
Calcium acetate
|
Feb 5, 2018
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (44 kB)
|
|
|
711
|
Glucan
|
Dec 26, 2017
|
FDA has no questions (in PDF) (49 kB)
|
|
|
710
|
Basic methacrylate copolymer
|
Dec 8, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (50 kB)
|
|
|
709
|
Pyrroloquinoline quinone disodium salt
|
Mar 6, 2018
|
FDA has no questions (in PDF) (79 kB)
|
|
|
708
|
Triacylglycerol lipase from Rhizopus oryzae produced in Aspergillus niger
|
Oct 10, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (52 kB)
|
|
|
707
|
Glucose oxidase from Penicillium produced in Trichoderma reesei
|
Nov 24, 2017
|
FDA has no questions (in PDF) (51 kB)
|
|
|
706
|
Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract
|
Aug 17, 2017
|
FDA has no questions (in PDF) (93 kB)
|
|
|
705
|
Distarch phosphate
|
Nov 9, 2017
|
FDA has no questions (in PDF) (63 kB)
|
|
|
704
|
Corn oil (by-product of ethanol production)
|
Oct 10, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (67 kB)
|
|
|
703
|
Alpha-glucosidase from Aspergillus niger produced by Trichoderma reesi
|
Nov 9, 2017
|
FDA has no questions (in PDF) (128 kB)
|
|
|
702
|
Purified steviol glycosides
|
Sep 28, 2017
|
FDA has no questions (in PDF) (65 kB)
|
|
|
701
|
Pyrroloquinoline quinone disodium salt
|
Sep 8, 2017
|
FDA has no questions (in PDF) (68 kB)
|
|
|
700
|
Paracoccus carotinifaciens extract containing carotenoids
|
Oct 23, 2017
|
FDA has no questions; some uses may require a color additive listing (in PDF) (99 kB)
|
|
|
699
|
Trehalase from Myceliophthora sepedonium produced by Aspergillus niger
|
Nov 13, 2017
|
FDA has no questions (in PDF) (67 kB)
|
|
|
698
|
Paramylon isolate from Euglena gracilis
|
Jul 19, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (105 kB)
|
|
|
697
|
Dried biomass of Euglena gracilis
|
Jul 19, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (105 kB)
|
|
|
696
|
Dolomite
|
Oct 3, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (53 kB)
|
|
|
695
|
Dimethyl ether
|
Aug 29, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (46 kB)
|
|
|
694
|
Pyrroloquinoline quinone disodium salt (PQQ)
|
Sep 28, 2017
|
FDA has no questions (in PDF) (72 kB)
|
|
|
693
|
D-psicose
|
Aug 28, 2017
|
FDA has no questions (in PDF) (97 kB)
|
|
|
692
|
Quinoa sprout extract
|
Nov 3, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (33 kB)
|
|
|
691
|
Bacillus coagulans SANK 70258 spore preparation
|
Aug 28, 2017
|
FDA has no questions (in PDF) (54 kB)
|
|
|
690
|
Fruit and vegetable vitamin extract
|
Aug 1, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (117 kB)
|
|
|
689
|
Phospholipase C from Bacillus thuringiensis produced in Bacillus licheniformis
|
Aug 4, 2017
|
FDA has no questions (in PDF) (54 kB)
|
|
|
688
|
Sodium thiocyanate
|
Aug 25, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (47 kB)
|
|
|
687
|
Inulin from Agave tequilana
|
May 8, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (54 kB)
|
|
|
686
|
Curcumin from turmeric (Curcuma longa L.)
|
Jul 11, 2017
|
FDA has no questions (in PDF) (152 kB)
|
|
|
685
|
Lactobacillus plantarum strain 299v
|
Oct 31, 2017
|
FDA has no questions (in PDF) (44 kB)
|
|
|
684
|
Mung bean protein isolate
|
Aug 4, 2017
|
FDA has no questions (in PDF) (119 kB)
|
|
|
683
|
Canola protein isolate
|
May 10, 2017
|
FDA has no questions (in PDF) (75 kB)
|
|
|
682
|
Lecithin from canola
|
Jul 7, 2017
|
FDA has no questions (in PDF) (151 kB)
|
|
|
681
|
Dried isomaltulose syrup
|
Jun 21, 2017
|
FDA has no questions (in PDF) (151 kB)
|
|
|
680
|
Alpha-L-arabinofuranosidase from Talaromyces pinophilus produced by Trichoderma reesei
|
May 24, 2017
|
FDA has no questions (in PDF) (101 kB)
|
|
|
679
|
Orange juice desugared by fermentation
|
May 10, 2017
|
FDA has no questions (in PDF) (67 kB)
|
|
|
678
|
Alpha-cyclodextrin
|
Apr 14, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (49 kB)
|
|
|
677
|
Docosahexaenoic acid oil produced in Schizochytrium sp.
|
May 2, 2017
|
FDA has no questions (in PDF) (101 kB)
|
|
|
676
|
Colicin preparations
|
May 15, 2017
|
FDA has no questions (in PDF) (90 kB)
|
|
|
675
|
Xylanase enzyme preparation produced by Trichoderma reesei carrying a xylanase gene from Talaromyces leycettanus
|
Apr 6, 2017
|
FDA has no questions (in PDF) (76 kB)
|
|
|
674
|
Isomalto-oligosaccharides
|
Jul 5, 2017
|
FDA has no questions (in PDF) (160 kB)
|
|
|
673
|
Algal fat derived from Prototheca moriformis (S7737)
|
Mar 27, 2017
|
FDA has no questions (in PDF) (76 kB)
|
|
|
672
|
Preparation containing five bacterial monophages specific to Shigella spp.
|
Mar 27, 2017
|
FDA has no questions (in PDF) (109 kB)
|
|
|
671
|
Galacto-oligosaccharides (GOS)
|
Apr 11, 2017
|
At the notifier's request, FDA ceased to evaluate this notice (in PDF) (62 kB)
|
|
|
670
|
Inactivated Bacillus coagulans GBI-30, 6086
|
Mar 15, 2017
|
FDA has no questions (in PDF) (47 kB)
|
|
|
669
|
Cows milk-derived lactoferrin
|
Mar 9, 2017
|
FDA has no questions (in PDF) (168 kB)
|
|
|
668
|
Sodium formate
|
Mar 9, 2017
|
FDA has no questions (in PDF) (106 kB)
|
|
|
667
|
Rebaudioside M
|
Feb 17, 2017
|
FDA has no questions (in PDF) (115 kB)
|
|
|
666
|
Chondroitin sulfate sodium
|
Mar 15, 2017
|
FDA has no questions (in PDF) (109 kB)
|
|
|
665
|
Lactoperoxidase system
|
Dec 14, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
664
|
Alpha-amylase from Cytophaga sp. expressed in Bacillus licheniformis
|
Jan 31, 2017
|
FDA has no questions (in PDF) (79 kB)
|
|
|
663
|
Distarch phosphate
|
Sep 30, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
662
|
Glucosylated steviol glycosides (minimum purity 95%)
|
Sep 29, 2016
|
FDA has no questions
|
|
|
661
|
Fucoidan concentrate from Fucus vesiculosus
|
Feb 10, 2017
|
FDA has no questions (in PDF) (85 kB)
|
|
|
660
|
Bacillus coagulans GBI-30, 6086 spores
|
Jan 13, 2017
|
FDA has no questions (in PDF) (81 kB)
|
|
|
659
|
Lacto-N-neotetraose
|
Nov 23, 2016
|
FDA has no questions
|
Dec 22, 2021
|
|
658
|
Grapefruit extract
|
Sep 28, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
657
|
Glucoamylase from Penicillum oxalicum produced in Aspergillus niger
|
Nov 23, 2016
|
FDA has no questions
|
|
|
656
|
Enzyme-modified steviol glycosides
|
Sep 28, 2016
|
FDA has no questions
|
|
|
655
|
Rice bran wax
|
Sep 20, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
654
|
Cocoa butter substitute manufactured using palm oil stearin and stearic acid
|
Dec 19, 2016
|
FDA has no questions
|
|
|
653
|
Lysophospholipase from Aspergillus nishimurae expressed in Trichoderma reesei.
|
Oct 13, 2016
|
FDA has no questions
|
|
|
652
|
Gamma linolenic acid safflower oil
|
Dec 16, 2016
|
FDA has no questions
|
|
|
651
|
Phospholipase A1 from Talaromyces leycettanus produced in Aspergillus niger
|
Nov 23, 2016
|
FDA has no questions
|
|
|
650
|
2'-O-fucosyllactose
|
Nov 23, 2016
|
FDA has no questions
|
Sep 11, 2020 Sep 9, 2020
|
|
649
|
β-galactosidase enzyme preparation from Bacillus circulans produced in Bacillus subtilis
|
Nov 28, 2016
|
FDA has no questions
|
|
|
648
|
Monoglycerides
|
Dec 13, 2016
|
FDA has no questions
|
May 24, 2024
|
|
647
|
D-psicose
|
Oct 11, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
646
|
Pecan shell fiber
|
Oct 12, 2016
|
FDA has no questions
|
|
|
645
|
Pullulanase from Bacillus deramificans and Bacillus acidopullulyticus expressed in Bacillus licheniformis
|
Nov 1, 2016
|
FDA has no questions
|
|
|
644
|
Non-fat dry goat milk and goat whey protein
|
Oct 11, 2016
|
FDA has no questions
|
|
|
643
|
Phosphatidylserine derived from fish
|
Jul 1, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
642
|
Camelina oil
|
Oct 12, 2016
|
FDA has no questions
|
|
|
641
|
Pyrroloquinoline quinone disodium salt
|
Oct 14, 2016
|
FDA has no questions
|
|
|
640
|
Esterified propoxylated glycerol
|
Sep 21, 2016
|
FDA has no questions
|
|
|
639
|
Zeaxanthin from marigold
|
Sep 28, 2016
|
FDA has no questions; some uses may require a color additive listing
|
|
|
638
|
High purity steviol glycosides (minimum purity 97%) consisting primarily of rebaudioside A
|
Jul 10, 2016
|
FDA has no questions
|
|
|
637
|
Phosphatidylserine derived from soy lecithin
|
Aug 4, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
636
|
Phosphatidylserine derived from sunflower lecithin
|
Jul 1, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
635
|
Nicotinamide riboside chloride
|
Aug 3, 2016
|
FDA has no questions
|
|
|
634
|
Calcium chloride
|
Aug 8, 2016
|
FDA has no questions
|
|
|
633
|
Concentrated milk protein with a ≥ 60:40 whey:casein ratio
|
Sep 21, 2016
|
FDA has no questions
|
|
|
632
|
Rebaudioside A from Yarrowia lipolytica
|
Jun 24, 2016
|
FDA has no questions
|
|
|
631
|
Triacylglycerol lipase from Fusarium oxysporum produced in Trichoderma reesei
|
Jul 18, 2016
|
FDA has no questions
|
|
|
630
|
Preparation containing the bacterial monophages, Fo1a and S16, specific to Salmonella
|
May 17, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
629
|
Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract
|
Jul 15, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
628
|
endo-1,4-beta-xylanase from Trichoderma reesei
|
Sep 14, 2016
|
FDA has no questions
|
|
|
627
|
Siraitia grosvenorii Swingle (Luo Han Guo) fruit juice concentrate
|
Oct 11, 2016
|
FDA has no questions
|
|
|
626
|
Steviol glycosides produced in Saccharomyces cerevisiae
|
May 27, 2016
|
FDA has no questions
|
|
|
625
|
Pyrroloquinoline quinone disodium salt (Resubmission of GRN 590)
|
Aug 18, 2016
|
FDA has no questions
|
|
|
624
|
D-allulose 3-epimerase from Arthrobacter globiformis M30 produced in Escherichia coli
|
Aug 18, 2016
|
FDA has no questions
|
|
|
623
|
Fructooligosaccharides
|
Aug 1, 2016
|
FDA has no questions
|
|
|
622
|
Emulsified fish oil
|
May 13, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
621
|
Emulsified algal oil
|
May 13, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
620
|
Galacto-oligosaccharides
|
Jul 21, 2016
|
FDA has no questions
|
|
|
619
|
Purified steviol glycosides
|
May 27, 2016
|
FDA has no questions
|
|
|
618
|
Purified seawater
|
May 27, 2016
|
FDA has no questions
|
|
|
617
|
α-amylase from Cytophaga sp. produced in Bacillus licheniformis
|
Apr 8, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
616
|
High-amylose cornstarch acetate
|
Jun 24, 2016
|
FDA has no questions
|
|
|
615
|
High-amylose cornstarch
|
Jun 24, 2016
|
FDA has no questions
|
|
|
614
|
Chromium polynicotinate
|
Apr 12, 2016
|
FDA has no questions
|
|
|
613
|
Apple peel powder
|
Mar 8, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
612
|
Fractionated whey protein isolate containing cows milk derived lactoferrin, lactoperoxidase, and transforming growth factor β2
|
May 19, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
611
|
Fractionated whey protein isolate containing cows milk derived lactoferrin, lactoperoxidase, and transforming growth factor β2
|
Apr 15, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
610
|
Isomaltodextrin
|
Jun 6, 2016
|
FDA has no questions
|
Jan 17, 2024
|
|
609
|
Rice protein
|
Jun 6, 2016
|
FDA has no questions
|
Jun 14, 2018
|
|
608
|
Pea protein concentrate
|
May 27, 2016
|
FDA has no questions
|
|
|
607
|
Glucosylated steviol glycosides (minimum purity 80%)
|
Oct 14, 2016
|
FDA has no questions
|
Nov 15, 2019
|
|
606
|
Vinyl acetate-vinyl laurate copolymers
|
May 27, 2016
|
FDA has no questions
|
|
|
605
|
Fructo-oligosaccharides
|
Mar 17, 2016
|
FDA has no questions
|
|
|
604
|
Baker's Yeast (Saccharomyces cerevisiae) expressing asparaginase II
|
Apr 27, 2016
|
FDA has no questions
|
|
|
603
|
Preparation containing the bacterial monophages, BP-63 and BP-12, specific to Salmonella
|
Jul 28, 2016
|
FDA has no questions
|
|
|
602
|
N-acetyl-D-neuraminic acid
|
Feb 1, 2016
|
FDA has no questions
|
|
|
601
|
Preparation of Bacillus coagulans strain MTCC 5856 spores
|
Apr 28, 2016
|
FDA has no questions
|
|
|
600
|
Hydroxytyrosol
|
May 13, 2016
|
FDA has no questions
|
|
|
599
|
Citrus fiber
|
Feb 17, 2016
|
FDA has no questions
|
|
|
598
|
Thermolysin enzyme preparation derived from Geobacillus stearothermophilus
|
Feb 29, 2016
|
FDA has no questions
|
|
|
597
|
Bacillus coagulans SNZ1969 spore preparation
|
Feb 29, 2016
|
FDA has no questions
|
|
|
596
|
Breadfruit flour
|
Feb 21, 2016
|
FDA has no questions
|
|
|
595
|
gamma-aminobutyric acid
|
Nov 10, 2015
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
594
|
α-amylase from Geobacillus stearothermophilus produced in Bacillus licheniformis
|
Dec 18, 2015
|
FDA has no questions
|
|
|
593
|
Colicin preparations
|
Dec 18, 2015
|
FDA has no questions
|
|
|
592
|
β-glucanase from Bacillus subtilis
|
Oct 7, 2015
|
FDA has no questions
|
|
|
591
|
Streptococcus salivarius K12
|
Jan 25, 2016
|
FDA has no questions (in PDF) (340 kB)
|
|
|
590
|
Pyrroloquinoline quinone
|
Jan 18, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
589
|
Xylanase from Aspergillus niger
|
Sep 17, 2015
|
FDA has no questions
|
|
|
588
|
Zeaxanthin from Capsicum annum (paprika)
|
Feb 29, 2016
|
FDA has no questions; some uses may require a color additive listing
|
|
|
587
|
Acetolactate decarboxylase from Bacillus brevis produced in Bacillus licheniformis
|
Sep 8, 2015
|
FDA has no questions
|
|
|
586
|
Taurine
|
Dec 9, 2015
|
FDA has no questions
|
|
|
585
|
1-methylcyclopropene complex
|
Jan 29, 2016
|
FDA has no questions
|
|
|
584
|
Cellulase from Penicillium funiculosum
|
Sep 30, 2015
|
FDA has no questions
|
|
|
583
|
Esterified propoxylated glycerol
|
Nov 12, 2015
|
FDA has no questions
|
|
|
582
|
Inulin from Agave tequilana
|
Nov 25, 2015
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
581
|
Un-hydrolyzed and hydrolyzed pea protein
|
Jan 25, 2016
|
FDA has no questions
|
|
|
580
|
Haematococcus pluvialis extract containing astaxanthin esters
|
Dec 18, 2015
|
FDA has no questions; some uses may require a color additive listing
|
|
|
579
|
Lactase from Bifidobacterium bifidum produced in Bacillus subtilis
|
Nov 5, 2015
|
FDA has no questions
|
|
|
578
|
Natamycin
|
Nov 6, 2015
|
FDA has no questions
|
|
|
577
|
Salts from dried mineral water (65% NaCl)
|
Dec 4, 2015
|
FDA has no questions
|
|
|
576
|
Oligofructose and inulin
|
Dec 9, 2015
|
FDA has no questions
|
|
|
575
|
Oat protein
|
Sep 18, 2015
|
FDA has no questions
|
|
|
574
|
Phospholipase C from Pseudomonas fluorescens
|
Jul 23, 2015
|
FDA has no questions
|
|
|
573
|
Calcium disodium ethylenediaminetetraacetate (EDTA)
|
Oct 22, 2015
|
FDA has no questions
|
|
|
572
|
Lactase from Bifidobacterium bifidum produced in Bacillus licheniformis
|
Aug 28, 2015
|
FDA has no questions
|
|
|
571
|
2'-Fucosyllactose
|
Nov 6, 2015
|
FDA has no questions
|
Nov 8, 2019
|
|
570
|
Magnesium lactate
|
Jan 26, 2016
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
569
|
Galacto-oligosaccharides (GOS)
|
Nov 25, 2015
|
FDA has no questions
|
|
|
568
|
Apoaequorin
|
Oct 21, 2015
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
567
|
Xylanase from Trichoderma reesei
|
May 8, 2015
|
FDA has no questions
|
|
|
566
|
Mannanase from Trichoderma reesei
|
May 21, 2015
|
FDA has no questions
|
|
|
565
|
Fucoidan from Undaria pinnatifida
|
Jul 2, 2015
|
FDA has no questions
|
|
|
564
|
Protease from Bacillus licheniformis
|
Jul 7, 2015
|
FDA has no questions
|
|
|
563
|
Protease from Fusarium venenatum
|
Jul 8, 2015
|
FDA has no questions
|
|
|
562
|
Bacillus subtilis
|
Apr 2, 2015
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
561
|
Bacillus pumilus
|
Apr 2, 2015
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
560
|
Bacillus licheniformis
|
Apr 2, 2015
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
559
|
Bacillus coagulans
|
Apr 2, 2015
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
558
|
Pectin esterase from Aspergillus tubingensis expressed in Trichoderma reesei
|
Jul 23, 2015
|
FDA has no questions
|
|
|
557
|
Polygalacturonase from Aspergillus tubingensis expressed in Trichoderma reesei
|
Jul 23, 2015
|
FDA has no questions
|
|
|
556
|
Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract
|
Jun 17, 2015
|
FDA has no questions
|
|
|
555
|
High purity steviol glycosides (minimum purity 95%) consisting primarily of rebaudioside A.
|
Apr 21, 2015
|
FDA has no questions
|
|
|
554
|
Synthetic amorphous silica
|
May 14, 2015
|
FDA has no questions
|
|
|
553
|
Algal oil (40% docosahexaenoic acid) derived from Schizochytrium sp.
|
Jun 19, 2015
|
FDA has no questions; some uses may require a color additive listing
|
|
|
552
|
Succinic acid
|
May 13, 2015
|
FDA has no questions
|
|
|
551
|
Aspartic protease derived from the flowers of Cynera cardunculus L.
|
Mar 26, 2015
|
FDA has no questions
|
|
|
550
|
Meso-zeaxanthin
|
Mar 27, 2015
|
FDA has no questions; some uses may require a color additive listing
|
|
|
549
|
Sodium salts of fatty acids from Mortierella alpina oil
|
Jun 5, 2015
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
548
|
High purity rebaudioside D
|
Apr 22, 2015
|
FDA has no questions
|
|
|
547
|
Lacto-N-neotetraose
|
Oct 2, 2015
|
FDA has no questions
|
|
|
546
|
2'-O-fucosyllactose
|
Sep 16, 2015
|
FDA has no questions
|
|
|
545
|
Phosphatidylserine derived from sunflower
|
Jun 5, 2015
|
FDA has no questions; some uses may require a color additive listing
|
|
|
544
|
β-glucans from oat bran
|
May 5, 2015
|
FDA has no questions
|
|
|
543
|
Lutein esters
|
Mar 16, 2015
|
FDA has no questions; some uses may require a color additive listing
|
|
|
542
|
Lutein
|
Mar 16, 2015
|
FDA has no questions; some uses may require a color additive listing
|
|
|
541
|
Insoluble fiber from citrus peel
|
Mar 24, 2015
|
FDA has no questions
|
|
|
540
|
Soybean leghemoglobin from Pichia pastoris
|
Nov 10, 2015
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
539
|
Fish meal-based lipid extract
|
Jun 15, 2015
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
538
|
Potassium-rich extract from Saccharum officinarum L. (sugarcane)
|
Apr 19, 2015
|
FDA has no questions
|
|
|
537
|
Short-chain fructo-oligosaccharides
|
Feb 6, 2015
|
FDA has no questions
|
|
|
536
|
High purity rebaudioside C
|
Feb 12, 2015
|
FDA has no questions
|
|
|
535
|
Beta-glucanase from Streptomyces violaceoruber
|
Feb 3, 2015
|
FDA has no questions
|
|
|
534
|
Hydrogenated lecithin from soy
|
Dec 22, 2014
|
FDA has no questions
|
|
|
533
|
Lecithin from canola
|
Mar 20, 2015
|
FDA has no questions
|
|
|
532
|
Complexation products of sodium tartrates with iron (III) chloride
|
Feb 6, 2015
|
FDA has no questions; some uses may require a color additive listing
|
|
|
531
|
Lactobacillus fermentum CECT5716
|
Mar 20, 2015
|
FDA has no questions
|
|
|
530
|
Extract of Apocynum venetum leaves
|
Nov 5, 2014
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
529
|
Seed of Phalaris canariensis L. (canary seed)
|
Jan 29, 2015
|
FDA has no questions
|
|
|
528
|
Preparation containing six bacterial monophages (LIST-36, LMSP-25, LMTA-34, LMTA-57, LMTA-94 and LMTA-148) specific to Listeria monocytogenes
|
Dec 23, 2014
|
FDA has no questions
|
|
|
527
|
Algal oil (87% oleic acid) derived from Prototheca moriformis strain S2532
|
Feb 6, 2015
|
FDA has no questions
|
|
|
526
|
Bacillus coagulans strain Unique IS2 spores preparation
|
Mar 23, 2015
|
FDA has no questions
|
|
|
525
|
Pea fiber
|
Sep 24, 2014
|
FDA has no questions; some uses may require a color additive listing
|
|
|
524
|
Phospholipase A2 enzyme preparation from Trichoderma reesei carrying a phospholipase A2 gene from Aspergillus nishimurae
|
Nov 10, 2014
|
FDA has no questions
|
|
|
523
|
l-leucine
|
Dec 11, 2014
|
FDA has no questions
|
|
|
522
|
Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract
|
Dec 8, 2014
|
FDA has no questions
|
|
|
521
|
Conjugated linoleic acid isomers
|
Dec 8, 2014
|
FDA has no questions
|
|
|
520
|
Hydrogen gas
|
Nov 28, 2014
|
FDA has no questions
|
|
|
519
|
Chlorella protothecoides strain S106 flour with 40-75% protein
|
Dec 23, 2014
|
FDA has no questions; some uses may require a color additive listing
|
|
|
518
|
Galacto-oligosaccharides
|
Dec 22, 2014
|
FDA has no questions
|
|
|
517
|
Natamycin
|
Nov 21, 2014
|
FDA has no questions
|
|
|
516
|
Steviol glycosides with rebaudioside A and stevioside as the principal components
|
Oct 31, 2014
|
FDA has no questions
|
|
|
515
|
D-beta-hydroxybutyrate ester
|
Mar 5, 2015
|
FDA has no questions
|
|
|
514
|
Sucrose fatty acid esters
|
Dec 3, 2014
|
FDA has no questions
|
|
|
513
|
Dried biomass of Euglena gracilis containing beta-1,3-glucan from Euglena gracilis
|
Jul 9, 2014
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
512
|
High purity Rebaudioside M
|
Oct 24, 2014
|
FDA has no questions
|
|
|
511
|
Citric acid esters of mono- and diglycerides
|
Nov 10, 2014
|
FDA has no questions
|
|
|
510
|
Acid lactase from Aspergillus oryzae expressed in Aspergillus niger
|
Sep 29, 2014
|
FDA has no questions
|
|
|
509
|
Glucose oxidase enzyme preparation derived from Penicillium chrysogenum
|
Nov 6, 2014
|
FDA has no questions
|
|
|
508
|
Salts from dried mineral water (65% NaCl)
|
Sep 24, 2014
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
507
|
Amylomaltase enzyme preparation from Bacillus amyloliquefaciens carrying an amylomaltase gene from Thermus thermophiles
|
Sep 11, 2014
|
FDA has no questions
|
|
|
506
|
Sacha inchi oil, a vegetable oil derived from Plukenetia volubilis.
|
Sep 10, 2014
|
FDA has no questions
|
|
|
505
|
Phosphodiesterase I enzyme preparation from Leptographium procerum
|
Aug 12, 2014
|
FDA has no questions
|
|
|
504
|
Milk protein concentrate and milk protein isolate (Resubmission of GRN 444)
|
Nov 21, 2014
|
FDA has no questions
|
|
|
503
|
Tamarind seed polysaccharide
|
Aug 12, 2014
|
FDA has no questions
|
|
|
502
|
Lactobacillus acidophilus La-14
|
Aug 19, 2014
|
FDA has no questions
|
|
|
501
|
L-theanine (chemically synthesized)
|
Jul 30, 2014
|
FDA has no questions
|
|
|
500
|
Hydroethanolic extract of Caralluma fimbriata
|
Aug 11, 2014
|
FDA has no questions
|
|
|
499
|
Magnesium L-threonate hydrate
|
Sep 3, 2014
|
FDA has no questions
|
|
|
498
|
D-psicose
|
Jun 12, 2014
|
FDA has no questions
|
|
|
497
|
Polyphenols from the fruit of Litchi chinensis Sonn. and from leaves of Camellia sinensis (L.) Sinensis
|
Jun 12, 2014
|
FDA has no questions; some uses may require a color additive listing
|
|
|
496
|
Aqueous extract of Brassica oleracea var. italica Plenck seeds.
|
Jan 11, 2016
|
FDA has no questions
|
|
|
495
|
Galacto-oligosaccharides
|
May 30, 2014
|
FDA has no questions
|
|
|
494
|
Fatty acid ethyl ester from anchovy or menhaden oil, standardized to approximately 50 percent palmitoleic acid
|
Dec 16, 2014
|
FDA has no questions
|
|
|
493
|
High purity steviol glycosides (minimum purity 95%)
|
May 30, 2014
|
FDA has no questions
|
|
|
492
|
Phytosterols and phytosterol esters
|
Jun 24, 2014
|
FDA has no questions
|
|
|
491
|
Rooster combs extract
|
Jun 6, 2014
|
FDA has no questions
|
|
|
490
|
Phospholipase A2 enzyme preparation from Trichoderma reesei
|
Mar 5, 2014
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
489
|
Galacto-oligosaccharides
|
May 22, 2014
|
FDA has no questions
|
|
|
488
|
Benzalkonium chloride
|
May 15, 2014
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
487
|
Dried citrus pulp
|
Jun 6, 2014
|
FDA has no questions
|
|
|
486
|
Oil from the seeds of Buglossoides arvensis
|
Dec 23, 2014
|
FDA has no questions
|
|
|
485
|
Beta-galactosidase enzyme preparation
|
Apr 15, 2014
|
FDA has no questions
|
|
|
484
|
Galacto-oligosaccharides
|
May 8, 2014
|
FDA has no questions
|
|
|
483
|
Aqueous extract of Emblica officinalis (Resubmission of GRN 322)
|
Apr 17, 2014
|
FDA has no questions
|
|
|
482
|
Beta-glucanase and xylanase enzyme preparation from Disporotrichum dimorphosporum
|
Jul 3, 2014
|
FDA has no questions
|
|
|
481
|
Meso-zeaxanthin
|
Apr 11, 2014
|
FDA has no questions; some uses may require a color additive listing
|
|
|
480
|
Dried aqueous extract derived from white kidney bean (Phaseolus vulgaris) (Resubmission of GRN 434)
|
May 30, 2014
|
FDA has no questions
|
|
|
479
|
Beta-glucanase, cellulase, and xylanase enzyme preparation from Talaromyces emersonii
|
Mar 7, 2014
|
FDA has no questions
|
|
|
478
|
Rice hull fiber
|
Sep 14, 2015
|
FDA has no questions
|
|
|
477
|
Long-chain inulin
|
Mar 4, 2014
|
FDA has no questions
|
|
|
476
|
Asparaginase enzyme preparation produced by genetically modified Bacillus subtilis
|
Feb 3, 2014
|
FDA has no questions
|
|
|
475
|
Citrus fruit extract
|
May 8, 2014
|
FDA has no questions
|
|
|
474
|
Piperine derived from the fruits of Piper nigrum L (black pepper) or P. longum (long pepper)
|
Sep 19, 2013
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
473
|
Purified steviol glycosides with rebaudioside X as the principal component
|
Dec 17, 2013
|
FDA has no questions
|
|
|
472
|
Xylanase enzyme preparation derived from Bacillus licheniformis carrying a gene encoding a modified xylanase from B. licheniformis
|
Jan 10, 2014
|
FDA has no questions
|
|
|
471
|
Annatto seed extract
|
May 19, 2014
|
FDA has no questions; some uses may require a color additive listing
|
|
|
470
|
Ethyl cellulose
|
Dec 16, 2013
|
FDA has no questions
|
|
|
469
|
Chlorella protothecoides strain S106 flour with 40-70% lipid (algal flour) (Resubmission of GRN 450)
|
Jun 7, 2013
|
FDA has no questions; some uses may require a color additive listing
|
|
|
468
|
Preparation containing the bacterial monophages, Fo1a and S16, specific to Salmonella
|
Dec 23, 2013
|
FDA has no questions
|
Apr 6, 2021 Dec 2, 2016
|
|
467
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni
|
Nov 25, 2013
|
FDA has no questions
|
|
|
466
|
Polyglycerol polyricinoleic acid
|
Sep 25, 2013
|
FDA has no questions
|
|
|
465
|
Cow's milk-derived lactoferrin
|
Feb 18, 2014
|
FDA has no questions
|
|
|
464
|
Cow's milk-derived lactoferrin
|
Feb 18, 2014
|
FDA has no questions
|
|
|
463
|
Lactobacillus acidophilus strain NP 28, Lactobacillus acidophilus strain NP51, Lactobacillus subsp. lactis strain NP7, and Pediococcus acidilactici strain NP3
|
Jan 16, 2014
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
462
|
Lipase enzyme preparation from modified Pseudomonas fluorescens Biovar I
|
Jun 6, 2013
|
FDA has no questions
|
|
|
461
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A)
|
Aug 14, 2013
|
FDA has no questions
|
|
|
460
|
Curcuminoids purified from turmeric (Curcuma longa L.)
|
Aug 23, 2013
|
FDA has no questions; some uses may require a color additive listing
|
|
|
459
|
Olive pulp extract
|
Mar 25, 2013
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
458
|
Xylooligosaccharides
|
Aug 23, 2013
|
FDA has no questions
|
|
|
457
|
Bacteroides xylanisolvens strain DSM 23964
|
Dec 16, 2013
|
FDA has no questions
|
|
|
456
|
Rebaudioside D purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside D)
|
Jul 1, 2013
|
FDA has no questions
|
|
|
455
|
Bifidobacterium breve M-16V
|
Sep 30, 2013
|
FDA has no questions
|
|
|
454
|
Bifidobacterium breve M-16V
|
Sep 27, 2013
|
FDA has no questions
|
|
|
453
|
Bifidobacterium breve M-16V
|
Sep 27, 2013
|
FDA has no questions
|
|
|
452
|
Enzyme-modified steviol glycosides
|
Jul 1, 2013
|
FDA has no questions
|
Dec 10, 2018
|
|
451
|
Calcium ascorbate with added threonate
|
Aug 5, 2013
|
FDA has no questions
|
|
|
450
|
Chlorella protothecoides S106 flour with 40-70% lipid
|
Apr 19, 2013
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
449
|
Medium chain triglycerides
|
Feb 19, 2014
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
448
|
Enzyme-modified steviol glycosides
|
May 3, 2013
|
FDA has no questions
|
|
|
447
|
Potato protein isolates
|
May 24, 2013
|
FDA has no questions
|
Feb 11, 2015 Jan 23, 2015
|
|
446
|
Red grape pomace extract
|
Apr 15, 2013
|
FDA has no questions; some uses may require a color additive listing
|
|
|
445
|
Bifidobacterium animalis subsp. lactis strains HN019, Bi-07, Bl-04 and B420
|
Apr 10, 2013
|
FDA has no questions
|
|
|
444
|
Milk protein concentrate and milk protein isolate
|
Mar 18, 2013
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
443
|
Shrimp-derived chitosan (Resubmission of GRN 170)
|
Feb 11, 2013
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
442
|
Volatile oil of mustard (white)
|
Jan 3, 2013
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
441
|
Sodium ferrous citrate
|
May 10, 2013
|
FDA has no questions; some uses may require a color additive listing
|
|
|
440
|
Lactobacillus reuteri strain NCIMB 30242
|
Feb 12, 2013
|
FDA has no questions
|
|
|
439
|
Iron complex of tartaric acid
|
Nov 9, 2012
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
438
|
Plant stanol esters
|
Jan 16, 2013
|
FDA has no questions
|
|
|
437
|
Beta-glucans from oat bran
|
Jan 27, 2013
|
FDA has no questions
|
|
|
436
|
Enzyme-modified dextrins
|
Jan 18, 2013
|
FDA has no questions
|
|
|
435
|
Preparation consisting of six bacterial monophage specific to Salmonella enterica (monophage cocktail)
|
Feb 22, 2013
|
FDA has no questions
|
Jan 17, 2024 Jun 28, 2021 Nov 15, 2019 Feb 13, 2015
|
|
434
|
Dried aqueous extract derived from white kidney bean (Phaseolus vulgaris)
|
Oct 10, 2012
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
433
|
Poloxamer fatty acid esters
|
Aug 3, 2012
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
432
|
Lutein diacetate (Resubmission of GRN 416)
|
Nov 14, 2012
|
FDA has no questions; some uses may require a color additive listing
|
|
|
431
|
Colostral whey protein concentrate
|
Oct 12, 2012
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
430
|
Sugar beet fiber
|
Mar 6, 2013
|
FDA has no questions
|
|
|
429
|
Lactobacillus casei strain Shirota
|
Dec 10, 2012
|
FDA has no questions
|
|
|
428
|
Asparaginase enzyme preparation from genetically modified Aspergillus niger
|
Nov 26, 2012
|
FDA has no questions
|
|
|
427
|
Corn hull fiber
|
Sep 12, 2012
|
FDA has no questions
|
|
|
426
|
Rice hull fiber
|
May 29, 2012
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
425
|
Canola oil (low erucic acid rapeseed oil)
|
Nov 20, 2012
|
FDA has no questions
|
|
|
424
|
C-c-phycocyanin-enriched water extract of the cyanobacterium Arthrospira maxima or Arthrospira platensis, (also known as Spirulina maxima or Spirulina platensis)
|
Dec 6, 2012
|
FDA has no questions; some uses may require a color additive listing
|
|
|
423
|
Cow's milk-derived lactoferrin
|
May 2, 2012
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
422
|
Modified baker's yeast Saccharomyces cerevisiae
|
Aug 31, 2012
|
FDA has no questions
|
|
|
421
|
Sucrose fatty acid esters
|
Aug 10, 2012
|
FDA has no questions
|
|
|
420
|
Calcium acid pyrophosphate
|
Aug 10, 2012
|
FDA has no questions
|
|
|
419
|
L-alpha-glycerylphosphorylcholine
|
Nov 20, 2012
|
FDA has no questions
|
|
|
418
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A)
|
Jun 7, 2012
|
FDA has no questions
|
|
|
417
|
Dried biomass of Arthrospira platensis also known as Spirulina platensis (spirulina)
|
Aug 10, 2012
|
FDA has no questions; some uses may require a color additive listing
|
|
|
416
|
Lutein diacetate
|
Mar 20, 2012
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
415
|
Heat-killed Propionibacterium freudenreichii ET-3 culture (powder)
|
Dec 26, 2012
|
FDA has no questions; some uses may require a color additive listing
|
|
|
414
|
L-lysine monohydrochloride
|
Nov 20, 2012
|
FDA has no questions
|
|
|
413
|
Beta glucans derived from Ganoderma lucidum mycelium
|
Aug 10, 2012
|
FDA has no questions
|
|
|
412
|
Chitin-glucan from Aspergillus niger
|
Jun 18, 2012
|
FDA has no questions
|
|
|
411
|
Egg yolk-derived phospholipids
|
Nov 20, 2012
|
FDA has no questions
|
|
|
410
|
Lactobacillus reuteri strain DSM 17938
|
Mar 26, 2012
|
FDA has no questions
|
|
|
409
|
Lactobacillus reuteri strain NCIMB 30242
|
Jan 10, 2012
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
408
|
Sulfuric acid and sodium sulfate
|
Mar 6, 2012
|
FDA has no questions
|
|
|
407
|
Polysaccharide complex of konjac glucomannan (konjac), sodium alginate, and xanthan gum (polysaccharide complex KAX)
|
Apr 10, 2012
|
FDA has no questions
|
|
|
406
|
1,4-α-glucan branching enzyme preparation from Bacillus subtilis strain 168 expressing the glucan branching enzyme gene from Aquifex aeolicus strain VF5
|
Sep 11, 2012
|
FDA has no questions
|
|
|
405
|
1,4-α-glucan branching enzyme preparation from Geobacillus stearothermophilus strain TRBE14
|
Sep 11, 2012
|
FDA has no questions
|
Dec 15, 2014
|
|
404
|
Cyclic dextrin, highly branched
|
Sep 10, 2012
|
FDA has no questions
|
|
|
403
|
Carnallite sea salt (magnesium chloride, potassium chloride, salt)
|
May 15, 2012
|
FDA has no questions
|
|
|
402
|
Peroxidase enzyme preparation derived from a genetically modified strain of Aspergillus niger
|
Nov 23, 2012
|
FDA has no questions
|
|
|
401
|
Erythritol
|
Mar 22, 2012
|
FDA has no questions
|
|
|
400
|
D-psicose
|
Jun 18, 2012
|
FDA has no questions
|
|
|
399
|
Preparation of Bacillus coagulans strain GBI-30, 6086 spores
|
Jul 31, 2012
|
FDA has no questions
|
|
|
398
|
Vegetable oil and tall oil derived phytosterol and phytosterol ester formulations
|
Feb 13, 2012
|
FDA has no questions
|
|
|
397
|
Chitosan from Aspergillus niger
|
Dec 19, 2011
|
FDA has no questions
|
|
|
396
|
Chlorella vulgaris strain Beij
|
Jul 5, 2012
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
395
|
Steviol glycosides with rebaudioside A and stevioside as the principal components
|
Jan 24, 2012
|
FDA has no questions
|
|
|
394
|
Dried biomass of Arthrospira platensis, also known as Spirulina platensis (Spirulina)
|
Jun 4, 2012
|
FDA has no questions; some uses may require a color additive listing
|
Dec 27, 2012
|
|
393
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A)
|
Jan 23, 2012
|
FDA has no questions
|
|
|
392
|
Oligofructose
|
May 7, 2012
|
FDA has no questions
|
|
|
391
|
Spirulina (Arthrospira platensis)
|
Oct 6, 2011
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
390
|
Suspended lutein
|
Jan 9, 2012
|
FDA has no questions; some uses may require a color additive listing
|
|
|
389
|
Steviol glycosides with stevioside as the principal component
|
Jan 18, 2012
|
FDA has no questions
|
|
|
388
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A)
|
Jan 9, 2012
|
FDA has no questions
|
|
|
387
|
Plant-derived esterified and non-esterified sterols and stanols (phytosterols)
|
Dec 19, 2011
|
FDA has no questions
|
|
|
386
|
Canola protein isolate and hydrolyzed canola protein isolate
|
Dec 28, 2011
|
FDA has no questions
|
|
|
385
|
Lutein
|
Dec 16, 2011
|
FDA has no questions; some uses may require a color additive listing
|
|
|
384
|
Algal oil derived from Chlorella protothecoides strain S106 (Cp algal oil)
|
Jun 13, 2012
|
FDA has no questions
|
|
|
383
|
Magnesium dihydrogen pyrophosphate (MDPP)
|
Dec 2, 2011
|
FDA has no questions
|
|
|
382
|
Erythritol
|
Nov 21, 2011
|
FDA has no questions
|
|
|
381
|
Phytic acid
|
Jun 4, 2012
|
FDA has no questions
|
|
|
380
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A)
|
Nov 28, 2011
|
FDA has no questions
|
|
|
379
|
Tuna oil
|
Nov 8, 2011
|
FDA has no questions
|
|
|
378
|
Cultured [dairy sources, sugars, wheat, malt, and fruit- and vegetable-based sources] fermented by [Streptococcus thermophilus, Bacillus coagulans, Lactobacillus acidophilus, Lactobacillus paracasei subsp. paracasei, Lactobacillus plantarum, Lactobacillus sakei, Lactobacillus bulgaricus and Proprionibacterium freudenreichii subsp. shermanii or mixtures of these strains]
|
Mar 26, 2012
|
FDA has no questions
|
|
|
377
|
Bifidobacterium animalis subsp. lactis strain Bf-6
|
Sep 29, 2011
|
FDA has no questions
|
|
|
376
|
Milk mineral concentrate
|
Oct 11, 2011
|
FDA has no questions
|
|
|
375
|
Enzyme-modified steviol glycosides
|
Sep 2, 2011
|
FDA has no questions
|
|
|
374
|
Maleated isoprenyl polymer with methoxy-polyethylene glycol (MIP-MPEG)
|
Aug 16, 2011
|
FDA has no questions
|
|
|
373
|
Rice bran fiber
|
Aug 19, 2011
|
FDA has no questions
|
|
|
372
|
Glucoamylase enzyme preparation from Trichoderma reesei expressing the glucoamylase gene from T. reesei (glucoamylase enzyme preparation)
|
Jul 25, 2011
|
FDA has no questions
|
|
|
371
|
Krill oil
|
Jul 22, 2011
|
FDA has no questions; some uses may require a color additive listing
|
|
|
370
|
Xylooligosaccharide
|
Mar 28, 2011
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
369
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni
|
Oct 11, 2011
|
FDA has no questions
|
|
|
368
|
Corn hull fiber
|
Apr 6, 2011
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
367
|
Purified steviol glycosides with rebaudioside A and stevioside as the principal components
|
Jul 8, 2011
|
FDA has no questions
|
Dec 7, 2016
|
|
366
|
Oat hull fiber
|
Apr 6, 2011
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
365
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A)
|
Aug 18, 2011
|
FDA has no questions
|
|
|
364
|
Bacteriophages LAND12, OLB1, TSRW1, DSMP1, DP1
|
Mar 16, 2011
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
363
|
Calcium disodium ethylenediaminetetraacetic acid (EDTA) and disodium EDTA
|
Jun 6, 2011
|
FDA has no questions
|
|
|
362
|
Levocarnitine
|
Mar 9, 2011
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
361
|
1,4-α-D-glucan branching enzyme preparation
|
Jan 31, 2011
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
360
|
Hydrolyzed sardine protein
|
May 16, 2011
|
FDA has no questions
|
|
|
359
|
Siraitia grosvenorii Swingle (Luo Han Guo) fruit extracts (SGFE)
|
Apr 11, 2011
|
FDA has no questions
|
|
|
358
|
Cyclic dextrin, highly branched
|
Feb 1, 2011
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
357
|
Lactobacillus acidophilus NCFM
|
Apr 19, 2011
|
FDA has no questions
|
|
|
356
|
Haematococcus pluvialis extract containing astaxanthin esters
|
Nov 15, 2010
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
355
|
Eicosapentaenoic acid (EPA)-rich triglyceride oil from Yarrowia lipolytica
|
Mar 7, 2011
|
FDA has no questions
|
|
|
354
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A)
|
Jul 15, 2011
|
FDA has no questions
|
|
|
353
|
High-selenium yeast
|
Mar 1, 2011
|
FDA has no questions
|
|
|
352
|
D-Tagatose
|
Feb 1, 2011
|
FDA has no questions
|
|
|
351
|
Dunaliella bardawil (Resubmission of GRN 276)
|
Feb 11, 2011
|
FDA has no questions; some uses may require a color additive listing
|
|
|
350
|
Saccharomyces cerevisiae strain P1Y0, a variant of S. cerevisiae parent strain UCD2034
|
Feb 4, 2011
|
FDA has no questions
|
|
|
349
|
Purified steviol glycosides with rebaudioside A and stevioside as the principal components
|
Jul 14, 2011
|
FDA has no questions
|
|
|
348
|
Stevioside purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (stevioside)
|
Jul 14, 2011
|
FDA has no questions
|
|
|
347
|
Caffeine
|
Nov 24, 2010
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
346
|
Freeze-dried fruit gac powder
|
Sep 10, 2010
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
345
|
Carboxypeptidase enzyme preparation from modified Aspergillus niger
|
Dec 22, 2010
|
FDA has no questions
|
|
|
344
|
Barley fiber
|
May 23, 2011
|
FDA has no questions
|
|
|
343
|
Wheat bran extract composed primarily of xylo- and arabinoxylo-oligosaccharides
|
Nov 22, 2010
|
FDA has no questions
|
|
|
342
|
Oat hull fiber
|
Dec 23, 2010
|
FDA has no questions
|
|
|
341
|
Quercetin
|
Nov 22, 2010
|
FDA has no questions; some uses may require a color additive listing
|
|
|
340
|
Theobromine
|
Nov 10, 2010
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
339
|
Polyglutamic acid
|
Nov 6, 2010
|
FDA has no questions
|
|
|
338
|
L-theanine extracted from tea leaves (Camellia sinensis)
|
Nov 5, 2010
|
FDA has no questions
|
|
|
337
|
Enzyme-modified steviol glycosides preparation (EMSGP)
|
Jun 17, 2011
|
FDA has no questions
|
|
|
336
|
ε-Polylysine (polylysine)
|
Aug 24, 2011
|
FDA has no questions
|
|
|
335
|
Pine tree phytosterol esters
|
Oct 27, 2010
|
FDA has no questions
|
|
|
334
|
Galacto-oligosaccharides
|
Oct 27, 2010
|
FDA has no questions
|
|
|
333
|
Acid fungal protease enzyme preparation from Trichoderma reesei expressing the gene encoding acid fungal protease from T. reesei
|
Sep 24, 2010
|
FDA has no questions
|
|
|
332
|
Oil from the seeds of the Korean pine (Pinus koraiensis) (Korean-pine nut oil)
|
Sep 24, 2010
|
FDA has no questions
|
|
|
331
|
Algal oil (Chlorella protothecoides)
|
Jun 1, 2010
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
330
|
Algal flour (Chlorella protothecoides)
|
Jun 1, 2010
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
329
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni
|
Sep 10, 2010
|
FDA has no questions
|
|
|
328
|
Polysaccharide complex of konjac glucomannan (konjac), sodium alginate, and xanthan gum (polysaccharide complex KAX)
|
May 20, 2011
|
Notice does not provide a basis for a GRAS determination
|
|
|
327
|
Cruciferin-rich canola/rapeseed protein isolate and napin-rich canola/rapeseed protein isolate
|
Aug 23, 2010
|
FDA has no questions
|
|
|
326
|
Arachidonic acid rich oil from M. alpina strain I49-N18
|
Oct 24, 2010
|
FDA has no questions
|
|
|
325
|
Olestra
|
Aug 30, 2010
|
FDA has no questions
|
|
|
324
|
Heat-killed Lactobacillus plantarum
|
Jul 7, 2010
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
323
|
Purified steviol glycosides with rebaudioside A and stevioside as the principal components
|
Jul 9, 2010
|
FDA has no questions
|
Mar 4, 2011
|
|
322
|
Aqueous extract of Emblica officinalis (Resubmission of GRN 295)
|
Jun 16, 2010
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
321
|
Synthetic amorphous silica (Resubmission of GRN 298)
|
Aug 18, 2010
|
FDA has no questions
|
|
|
320
|
Palm oil-derived carotenoids with β-carotene, α-carotene, γ-carotene, and lycopene
|
Sep 3, 2010
|
FDA has no questions; some uses may require a color additive listing
|
|
|
319
|
Micro-algal oil Ulkenia sp. SAM2179 (Resubmission of GRN 160)
|
Aug 4, 2010
|
FDA has no questions; some uses may require a color additive listing
|
|
|
318
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni
|
May 15, 2010
|
FDA has no questions
|
|
|
317
|
L-arginine
|
Jul 12, 2010
|
FDA has no questions
|
|
|
316
|
Sodium potassium hexametaphosphate
|
Jun 28, 2010
|
FDA has no questions
|
|
|
315
|
Transglucosidase enzyme preparation from Trichoderma reesei expressing the gene encoding transglucosidase from Aspergillus niger
|
May 4, 2010
|
FDA has no questions
|
|
|
314
|
Pork protein
|
Aug 11, 2010
|
FDA has no questions
|
|
|
313
|
Beef protein
|
Aug 11, 2010
|
FDA has no questions
|
|
|
312
|
Synthetic dihydrocapsiate
|
Jun 6, 2010
|
FDA has no questions
|
|
|
311
|
Krill-based phosphatidylserine
|
Jun 15, 2010
|
FDA has no questions; some uses may require a color additive listing
|
|
|
310
|
Potato fiber
|
Jun 10, 2010
|
FDA has no questions
|
|
|
309
|
Beta-glucan derived from Aureobasidium pullulans
|
Jun 14, 2010
|
FDA has no questions
|
|
|
308
|
L-leucine
|
Apr 30, 2010
|
FDA has no questions
|
|
|
307
|
Palm oil-derived tocols with tocotrienols and α-tocopherol as the principal components
|
Apr 23, 2010
|
FDA has no questions; some uses may require a color additive listing
|
|
|
306
|
Soybean oil with reduced palmitic and linolenic acids and increased oleic acid
|
Apr 7, 2010
|
FDA has no questions
|
Jul 7, 2014
|
|
305
|
Carnobacterium maltaromaticum strain CB1 (viable and heat-treated)
|
Apr 19, 2010
|
FDA has no questions
|
|
|
304
|
Purified steviol glycosides with rebaudioside A and stevioside as the principal components
|
Mar 22, 2010
|
FDA has no questions
|
|
|
303
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni
|
Mar 22, 2010
|
FDA has no questions
|
|
|
302
|
1,3-propanediol
|
Mar 5, 2010
|
FDA has no questions
|
|
|
301
|
Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract (SGFE)
|
Jan 15, 2010
|
FDA has no questions
|
Apr 8, 2011
|
|
300
|
Trisodium diphosphate
|
Dec 16, 2009
|
FDA has no questions
|
|
|
299
|
Lycopene from Escherichia coli expressing lycopene biosynthetic enzymes
|
Sep 22, 2009
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
298
|
Silicon dioxide
|
Oct 9, 2009
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
297
|
Erythritol fatty acid esters (Resubmission of GRN 203)
|
Dec 15, 2009
|
FDA has no questions
|
|
|
296
|
Lipase enzyme preparation from a genetically modified strain of Aspergillus niger
|
Oct 1, 2009
|
FDA has no questions
|
|
|
295
|
Aqueous extract of Emblica officinalis
|
Nov 23, 2009
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
294
|
Haematococcus pluvialis extract containing astaxanthin esters
|
Jan 6, 2010
|
FDA has no questions; some uses may require a color additive listing
|
|
|
293
|
Glutathione (Resubmission of GRN 244)
|
Dec 22, 2009
|
FDA has no questions
|
|
|
292
|
Cellulase enzyme preparation derived from a genetically modified strain of Myceliophthora thermophila
|
Sep 29, 2009
|
FDA has no questions
|
|
|
291
|
Crystalline lutein
|
Nov 6, 2009
|
FDA has no questions; some uses may require a color additive listing
|
|
|
290
|
L-arginine
|
Nov 2, 2009
|
FDA has no questions
|
|
|
289
|
Colicin E1 purified from Escherichia coli
|
Jun 25, 2009
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
288
|
Lactobacillus rhamnosus strain HN001
|
Nov 1, 2009
|
FDA has no questions
|
|
|
287
|
Purified steviol glycosides with rebaudioside A and stevioside as the principal components
|
Aug 28, 2009
|
FDA has no questions
|
|
|
286
|
Galacto-oligosaccharides
|
Sep 4, 2009
|
FDA has no questions
|
Jan 6, 2015 Apr 15, 2011
|
|
285
|
Galacto-oligosaccharides
|
Sep 4, 2009
|
FDA has no questions
|
Jan 6, 2015 Apr 15, 2011
|
|
284
|
Bakers yeast mannoprotein
|
Aug 28, 2009
|
FDA has no questions
|
|
|
283
|
Stearidonic acid soybean oil
|
Sep 4, 2009
|
FDA has no questions
|
|
|
282
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni
|
Aug 11, 2009
|
FDA has no questions
|
|
|
281
|
Lactobacillus rhamnosus strain HN001 produced in a milk-based medium
|
Aug 31, 2009
|
FDA has no questions
|
|
|
280
|
Whole and milled flaxseed
|
Aug 24, 2009
|
FDA has no questions
|
|
|
279
|
Phosphatidylserine derived from fish
|
Jul 25, 2009
|
FDA has no questions
|
|
|
278
|
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni
|
Jul 20, 2009
|
FDA has no questions
|
|
|
277
|
Maltotetraohydrolase enzyme preparation from Bacillus licheniformis expressing a modified maltotetraohydrolase gene from Pseudomonas stutzeri
|
May 15, 2009
|
FDA has no questions
|
|
|
276
|
Dunaliella bardawil alga
|
Mar 6, 2009
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
275
|
Purified steviol glycosides with rebaudioside A as the principal component
|
Jun 11, 2009
|
FDA has no questions
|
|
|
274
|
Branching glycosyltransferase enzyme preparation from Bacillus subtilis expressing a branching glycosyltransferase gene from Rhodothermus obamensis
|
Jun 25, 2009
|
FDA has no questions
|
|
|
273
|
Baobab (Adansonia digitata) dried fruit pulp
|
Jul 25, 2009
|
FDA has no questions
|
Sep 5, 2013
|
|
272
|
Triple salt of magnesium, ammonium, and potassium chloride, hexahydrate
|
Jun 24, 2009
|
FDA has no questions
|
|
|
271
|
Ferrous ammonium phosphate
|
May 29, 2009
|
FDA has no questions
|
|
|
270
|
Polyglycerol polyricinoleic acid
|
Jun 15, 2009
|
FDA has no questions
|
|
|
269
|
Polyglycerol fatty acid esters with a degree of polymerization of 11 to 40 for the polyglycerol backbone
|
May 21, 2009
|
FDA has no questions
|
|
|
268
|
Bifidobacterium longum strain BB536
|
Jul 8, 2009
|
FDA has no questions
|
|
|
267
|
Protein glutaminase enzyme preparation derived from Chryseobacterium proteolyticum
|
Jul 15, 2009
|
FDA has no questions
|
|
|
266
|
Polyglycerol polyricinoleate
|
May 29, 2009
|
FDA has no questions
|
|
|
265
|
Glycerophospholipid cholesterol acyltransferase (GCAT) enzyme preparation from Bacillus licheniformis expressing a modified GCAT gene from Aeromonas salmonicida subsp. salmonicida
|
Jun 13, 2009
|
FDA has no questions
|
Jul 15, 2010
|
|
264
|
Sweet lupin flour
|
Dec 16, 2008
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
263
|
Sweet lupin fiber
|
Dec 16, 2008
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
262
|
Sweet lupin protein
|
Dec 16, 2008
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
261
|
Oat hull fiber
|
Feb 3, 2009
|
FDA has no questions
|
Oct 14, 2016
|
|
260
|
High-selenium yeast (Resubmission of GRN 241)
|
Mar 9, 2009
|
FDA has no questions
|
|
|
259
|
Catechins from green tea extract (Resubmission of GRN 225)
|
Aug 21, 2009
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
258
|
Sucromalt
|
Feb 3, 2009
|
FDA has no questions
|
|
|
257
|
gamma-Amino butyric acid
|
Dec 22, 2008
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
256
|
High linolenic acid flaxseed oil
|
Jan 16, 2009
|
FDA has no questions
|
|
|
255
|
Bovine globulin (Resubmission of GRN 234)
|
Dec 24, 2008
|
FDA has no questions
|
|
|
254
|
Lactobacillus reuteri strain DSM 17938
|
Nov 18, 2008
|
FDA has no questions
|
|
|
253
|
Rebaudioside A purified from Stevia rebaudiana (Bertoni) Bertoni
|
Dec 17, 2008
|
FDA has no questions
|
|
|
252
|
Rebaudioside A purified from Stevia rebaudiana (Bertoni) Bertoni
|
Dec 17, 2008
|
FDA has no questions
|
|
|
251
|
Carbon monoxide
|
Jan 25, 2012
|
FDA has no questions
|
|
|
250
|
Plant sterols and stanols from pine trees
|
Feb 9, 2009
|
FDA has no questions
|
|
|
249
|
Synthetic dihydrocapsiate
|
Mar 9, 2009
|
FDA has no questions
|
|
|
248
|
Sucrose fatty acid esters (i.e., sucrose monoesters of lauric acid, palmitic acid, and stearic acid) manufactured by reaction of sucrose with vinyl esters of lauric, palmitic, and stearic acids
|
Oct 24, 2008
|
FDA has no questions
|
|
|
247
|
Modified gum acacia
|
Oct 7, 2008
|
FDA has no questions
|
|
|
246
|
Isomalto-oligosaccharide mixture (Resubmission of GRN 172)
|
Feb 10, 2009
|
FDA has no questions
|
Jun 1, 2016
|
|
245
|
Menaquinone-7
|
Jun 2, 2008
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
244
|
Glutathione
|
May 9, 2008
|
At the notifier's request, FDA ceased to evaluate this notice
|
|
|
243
|
D-Ribose (Resubmission of GRN 100)
|
Nov 10, 2008
|
FDA has no questions
|
|
|
242
|
Krill oil
|
Oct 14, 2008
|
FDA h |